Updated on 2024/12/17

写真a

 
TAKAO Tomoka
 
Organization
Faculty of Medicine, Dentistry and Pharmaceutical Sciences Lecturer
Position
Lecturer
External link

Degree

  • 博士(医学) ( 2011.9   九州大学 )

  • 修士(保健学) ( 2007.3   神戸大学 )

  • 学士(理学) ( 2005.3   岡山理科大学 )

Research Interests

  • cell signaling

  • 間葉系幹細胞

  • stem cells

  • endometriosis

  • 軟骨;骨再生

  • 軟骨再生

  • 胎盤

  • 再生医療

  • 組織修復

  • 軟骨・骨形成

  • 多能性幹細胞

Research Areas

  • Life Science / Obstetrics and gynecology  / 胎盤・子宮

  • Life Science / Molecular biology  / 骨・軟骨代謝

  • Life Science / Molecular biology  / 幹細胞

Education

  • kyushu University    

    2007.4 - 2011.3

      More details

  • Kobe University   医学系研究科   保健学専攻

    2005.4 - 2007.3

      More details

  • Okayama University of Science   理学部   生物化学科臨床生物化学専攻

    2001.4 - 2005.3

      More details

Research History

  • 岡山大学学術研究院医歯薬学域(医学系)   研究准教授

    2024.7

      More details

  • 岡山大学学術研究院医歯薬学域(医学系)   講師

    2023.2

      More details

  • Okayama University   組織機能修復学分野   Assistant Professor

    2021.4 - 2023.1

      More details

    Country:Japan

    researchmap

  • Keio University   School of Medicine Department of Obstetrics and Gynecology (Obstetrics)

    2019.12 - 2022.11

      More details

  • Okayama University   Graduate School of Medicine , Dentistry and Pharmaceutical Sciences   Assistant Professor

    2019.12 - 2021.3

      More details

  • Keio University   産科婦人科学教室

    2016.8 - 2019.11

      More details

  • Kyoto University   医学研究科AKプロジェクト

    2013.4 - 2016.8

      More details

  • Kyushu University   環境発達医学研究センター

    2012.4 - 2013.3

      More details

  • Kyushu University   環境発達医学研究センター

    2011.4 - 2012.3

      More details

▼display all

Professional Memberships

▼display all

Committee Memberships

  • 日本組織培養学会   評議員  

    2023.12   

      More details

  • 岡山大学   医療系等研究開発戦略委員会委員  

    2023.4   

      More details

  • 岡山大学   基礎・社会医学系教育企画委員  

    2020.4   

      More details

 

Papers

  • Efficient Production of Chondrocyte Particles from Human iPSC-Derived Chondroprogenitors Using a Plate-Based Cell Self-Aggregation Technique. International journal

    Shojiro Hanaki, Daisuke Yamada, Tomoka Takao, Ryosuke Iwai, Takeshi Takarada

    International journal of molecular sciences   25 ( 22 )   2024.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The limited capacity of articular cartilage for self-repair is a critical challenge in orthopedic medicine. Here, we aimed to develop a simplified method of generating chondrocyte particles from human-induced pluripotent stem cell-derived expandable limb-bud mesenchymal cells (ExpLBM) using a cell self-aggregation technique (CAT). ExpLBM cells were induced to form chondrocyte particles through a stepwise differentiation protocol performed on a CAT plate (prevelex-CAT®), which enables efficient and consistent production of an arbitrary number of uniformly sized particles. Histological and immunohistochemical analyses confirmed that the generated chondrocyte particles expressed key cartilage markers, such as type II collagen and aggrecan, but not hypertrophic markers, such as type X collagen. Additionally, when these particles were transplanted into osteochondral defects in rats with X-linked severe combined immunodeficiency, they demonstrated successful engraftment and extracellular matrix production, as evidenced by Safranin O and Toluidine Blue staining. These data suggest that the plate-based CAT system offers a robust and scalable approach to produce a large number of chondrocyte particles in a simplified and efficient manner, with potential application to cartilage regeneration. Future studies will focus on refining the system and exploring its clinical applications to the treatment of cartilage defects.

    DOI: 10.3390/ijms252212063

    PubMed

    researchmap

  • A novel chondrocyte sheet fabrication using human-induced pluripotent stem cell-derived expandable limb-bud mesenchymal cells Reviewed International journal

    Tomoka Takao, Masato Sato, Yuki Fujisawa, Eriko Toyoda, Daisuke Yamada, Yukio Hitsumoto, Eiji Nakata, Toshifumi Ozaki, Takeshi Takarada

    Stem Cell Research & Therapy   14 ( 1 )   34 - 34   2023.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Background

    Cell sheet fabrication for articular cartilage regenerative medicine necessitates a large number of chondrocytes of consistent quality as a cell source. Previously, we have developed human-induced pluripotent stem cell (iPSC)-derived expandable PRRX1+ limb-bud mesenchymal cells (ExpLBM) with stable expansion and high chondrogenic capacity, while in this study; our ExpLBM technology was combined with cell sheet engineering to assess its potential as a stable cell source for articular cartilage regeneration.

    Methods

    ExpLBM cells derived from human-induced pluripotent stem cells (hiPSCs), including 414C2 and Ff-KVs09 (HLA homozygous), were seeded onto a culture plate and two-dimensional chondrogenic induction (2-DCI) was initiated. After 2-DCI, ExpLBM-derived chondrocytes were stripped and transferred to temperature-responsive culture inserts and the chondrocyte sheets were histologically examined or transplanted into osteochondral knee defects of immunodeficient rats.

    Results

    Immunohistochemistry revealed that ExpLBM-derived cell sheets were positive for Safranin O, COL2, and ACAN but that they were negative for COL1 and RUNX2. Furthermore, the engrafted tissues in osteochondral knee defects in immunodeficient rats were stained with SafO, human VIMENTIN, ACAN, and COL2.

    Conclusions

    The present study is the first to report the chondrocyte sheet fabrication with hiPSC-derived cell source. hiPSC-derived ExpLBM would be a promising cell source for cell sheet technology in articular cartilage regenerative medicine.

    DOI: 10.1186/s13287-023-03252-4

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1186/s13287-023-03252-4/fulltext.html

  • A protocol to induce expandable limb-bud mesenchymal cells from human pluripotent stem cells. Reviewed International journal

    Tomoka Takao, Daisuke Yamada, Takeshi Takarada

    STAR protocols   3 ( 4 )   101786 - 101786   2022.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Here, we present a protocol for the selective differentiation of human pluripotent stem cells mimicking human developmental processes into expandable PRRX1+ limb-bud mesenchymal (ExpLBM) cells. This approach enables expansion through serial passage while maintaining capacity for chondrogenic differentiation. For complete details on the use and execution of this protocol, please refer to Yamada et al. (2021, 2022).

    DOI: 10.1016/j.xpro.2022.101786

    PubMed

    researchmap

  • Identification of Surface Antigens That Define Human Pluripotent Stem Cell-Derived PRRX1+Limb-Bud-like Mesenchymal Cells Reviewed International journal

    Daisuke Yamada, Tomoka Takao, Masahiro Nakamura, Toki Kitano, Eiji Nakata, Takeshi Takarada

    International Journal of Molecular Sciences   23 ( 5 )   2661 - 2661   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Stem cell-based therapies and experimental methods rely on efficient induction of human pluripotent stem cells (hPSCs). During limb development, the lateral plate mesoderm (LPM) produces limb-bud mesenchymal (LBM) cells that differentiate into osteochondroprogenitor cells and form cartilage tissues in the appendicular skeleton. Previously, we generated PRRX1-tdTomato reporter hPSCs to establish the protocol for inducing the hPSC-derived PRRX1+ LBM-like cells. However, surface antigens that assess the induction efficiency of hPSC-derived PRRX1+ LBM-like cells from LPM have not been identified. Here, we used PRRX1-tdTomato reporter hPSCs and found that high pluripotent cell density suppressed the expression of PRRX1 mRNA and tdTomato after LBM-like induction. RNA sequencing and flow cytometry suggested that PRRX1-tdTomato+ LBM-like cells are defined as CD44high CD140Bhigh CD49f−. Importantly, other hPSC lines, including four human induced pluripotent stem cell lines (414C2, 1383D2, HPS1042, HPS1043) and two human embryonic stem cell lines (SEES4, SEES7), showed the same results. Thus, an appropriate cell density of hPSCs before differentiation is a prerequisite for inducing the CD44high CD140Bhigh CD49f− PRRX1+ LBM-like cells.

    DOI: 10.3390/ijms23052661

    PubMed

    researchmap

  • Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway Reviewed International journal

    Tomoka Takao, Hirotaka Masuda, Takashi Kajitani, Fumie Miki, Kaoru Miyazaki, Yushi Yoshimasa, Satomi Katakura, Shoko Tomisato, Sayaka Uchida, Hiroshi Uchida, Mamoru Tanaka, Tetsuo Maruyama

    Stem Cell Research & Therapy   13 ( 1 )   225 - 225   2022.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Background

    Distinct subsets of cancer stem cells (CSCs) drive the initiation and progression of malignant tumors via enhanced self-renewal and development of treatment/apoptosis resistance. Endometrial CSC-selective drugs have not been successfully developed because most endometrial cell lines do not contain a sufficient proportion of stable CSCs. Here, we aimed to identify endometrial CSC-containing cell lines and to search for endometrial CSC-selective drugs.

    Methods

    We first assessed the presence of CSCs by identifying side populations (SPs) in several endometrial cancer cell lines. We then characterized cell viability, colony-formation, transwell invasion and xenotransplantion capability using the isolated SP cells. We also conducted real-time RT-PCR, immunoblot and immunofluorescence analyses of the cells’ expression of CSC-associated markers. Focusing on 14 putative CSC-selective drugs, we characterized their effects on the proliferation and apoptosis of endometrial cancer cell lines, examining cell viability and annexin V staining. We further examined the inhibitory effects of the selected drugs, focusing on proliferation, invasion, expression of CSC-associated markers and tumor formation.

    Results

    We focused on HHUA cells, an endometrial cancer cell line derived from a well-differentiated endometrial adenocarcinoma. HHUA cells contained a sufficient proportion of stable CSCs with an SP phenotype (HHUA-SP). HHUA-SP showed greater proliferation, colony-formation, and invasive capabilities compared with the main population of HHUA cells (HHUA-MP). HHUA-SP generated larger tumors with higher expression of proliferation-related markers, Ki67, c-MYC and phosphorylated ERK compared with HHUA-MP when transplanted into immunodeficient mice. Among the 14 candidate drugs, sorafenib, an inhibitor of RAF pathways and multiple kinase receptors, inhibited cell proliferation and invasion in both HHUA-SP and -MP, but more profoundly in HHUA-SP. In vivo treatment with sorafenib for 4 weeks reduced the weights of HHUA-SP-derived tumors and decreased the expression of Ki67, ZEB1, and RAF1.

    Conclusions

    Our results suggest that HHUA is a useful cell line for discovery and identification of endometrial CSC-selective drugs, and that sorafenib may be an effective anti-endometrial cancer drug targeting endometrial CSCs.

    DOI: 10.1186/s13287-022-02888-y

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1186/s13287-022-02888-y/fulltext.html

  • Optogenetic regulation of embryo implantation in mice using photoactivatable CRISPR-Cas9. Reviewed International journal

    Tomoka Takao , Moritoshi Sato , Tetsuo Maruyama

    Proceedings of the National Academy of Sciences of the United States of America   117 ( 46 )   28579 - 28581   2020.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Proceedings of the National Academy of Sciences  

    Embryo implantation is achieved upon successful interaction between a fertilized egg and receptive endometrium and is mediated by spatiotemporal expression of implantation-associated molecules including leukemia inhibitory factor (LIF). Here we demonstrate, in mice, that LIF knockdown via a photoactivatable CRISPR-Cas9 gene editing system and illumination with a light-emitting diode can spatiotemporally disrupt fertility. This system enables dissection of spatiotemporal molecular mechanisms associated with embryo implantation and provides a therapeutic strategy for temporal control of reproductive functions in vivo.

    DOI: 10.1073/pnas.2016850117

    PubMed

    researchmap

    Other Link: https://syndication.highwire.org/content/doi/10.1073/pnas.2016850117

  • Establishment of a tTA-dependent photoactivatable Cre recombinase knock-in mouse model for optogenetic genome engineering Reviewed International journal

    Tomoka Takao, Yuichi Hiraoka, Kenji Kawabe, Daisuke Yamada, Lu Ming, Kohichi Tanaka, Moritoshi Sato, Takeshi Takarada

    Biochemical and Biophysical Research Communications   526 ( 1 )   213 - 217   2020.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    The Cre-loxP recombination system is widely used to generate genetically modified mice for biomedical research. Recently, a highly efficient photoactivatable Cre (PA-Cre) based on reassembly of split Cre fragments has been established. This technology enables efficient DNA recombination that is activated upon blue light illumination with spatiotemporal precision. In this study, we generated a tTA-dependent photoactivatable Cre-loxP recombinase knock-in mouse model (TRE-PA-Cre mice) using a CRISPR/Cas9 system. These mice were crossed with ROSA26-tdTomato mice (Cre reporter mouse) to visualize DNA recombination as marked by tdTomato expression. We demonstrated that external noninvasive LED blue light illumination allows efficient DNA recombination in the liver of TRE-PA-Cre:ROSA26-tdTomato mice transfected with tTA expression vectors using hydrodynamic tail vein injection. The TRE-PA-Cre mouse established here promises to be useful for optogenetic genome engineering in a noninvasive, spatiotemporal, and cell-type specific manner in vivo.

    DOI: 10.1016/j.bbrc.2020.03.015

    PubMed

    researchmap

  • PRRX1 upregulates PD-L1 in human mesenchymal stem cells Reviewed

    Taro Osawa, Daisuke Yamada, Tomoka Takao, Lu Ming, Takeshi Takarada

    In Vitro Cell Dev Biol Anim   2024.4

     More details

    Language:English  

    researchmap

  • PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours. International journal

    Shota Takihira, Daisuke Yamada, Tatsunori Osone, Tomoka Takao, Masakiyo Sakaguchi, Michiyuki Hakozaki, Takuto Itano, Eiji Nakata, Tomohiro Fujiwara, Toshiyuki Kunisada, Toshifumi Ozaki, Takeshi Takarada

    British journal of cancer   130 ( 9 )   1493 - 1504   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Paired related-homeobox 1 (PRRX1) is a transcription factor in the regulation of developmental morphogenetic processes. There is growing evidence that PRRX1 is highly expressed in certain cancers and is critically involved in human survival prognosis. However, the molecular mechanism of PRRX1 in cancer malignancy remains to be elucidated. METHODS: PRRX1 expression in human Malignant peripheral nerve sheath tumours (MPNSTs) samples was detected immunohistochemically to evaluate survival prognosis. MPNST models with PRRX1 gene knockdown or overexpression were constructed in vitro and the phenotype of MPNST cells was evaluated. Bioinformatics analysis combined with co-immunoprecipitation, mass spectrometry, RNA-seq and structural prediction were used to identify proteins interacting with PRRX1. RESULTS: High expression of PRRX1 was associated with a poor prognosis for MPNST. PRRX1 knockdown suppressed the tumorigenic potential. PRRX1 overexpressed in MPNSTs directly interacts with topoisomerase 2 A (TOP2A) to cooperatively promote epithelial-mesenchymal transition and increase expression of tumour malignancy-related gene sets including mTORC1, KRAS and SRC signalling pathways. Etoposide, a TOP2A inhibitor used in the treatment of MPNST, may exhibit one of its anticancer effects by inhibiting the PRRX1-TOP2A interaction. CONCLUSION: Targeting the PRRX1-TOP2A interaction in malignant tumours with high PRRX1 expression might provide a novel tumour-selective therapeutic strategy.

    DOI: 10.1038/s41416-024-02632-8

    PubMed

    researchmap

  • Development of cartilage tissue using a stirred bioreactor and human iPSC-derived limb bud mesenchymal cells. International journal

    Yuki Fujisawa, Tomoka Takao, Daisuke Yamada, Takeshi Takarada

    Biochemical and biophysical research communications   687   149146 - 149146   2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Production of cartilaginous particles for regenerative medicine requires a large supply of chondrocytes and development of suitable production techniques. Previously, we successfully produced human induced pluripotent stem cell (hiPSC)-derived limb bud mesenchymal cells (ExpLBM cells) with a high chondrogenic differentiation potential that stably proliferate. It may be possible to use these cells in combination with a stirred bioreactor to develop a tissue-engineered cell culture technology with potential for scale-up to facilitate production of large amounts of cartilaginous particles. ExpLBM cells derived from 414C2 and Ff-I 14s04 (human leukocyte antigen homozygous) hiPSCs were seeded into a stirred bioreactor containing cartilage induction medium. To characterize the cartilaginous particles produced, we performed real-time quantitative reverse transcription-polymerase chain reaction and histological analyses. Additionally, we transplanted the cartilage tissue into osteochondral defects of immunocompromised rats to assess its functionality, and evaluated engraftment of the grafted tissue. We successfully produced large amounts of cartilaginous particles via cartilage induction culture in a stirred bioreactor. This tissue exhibited significantly increased expression levels of type II collagen (COL2), aggrecan (ACAN), and SRY-box transcription factor 9 (SOX9), as well as positive Safranin O and Toluidine blue staining, indicating that it possesses characteristics of hyaline cartilage. Furthermore, engrafted tissues in osteochondral knee defects of immunodeficient rats were positively stained for human vimentin, COL2, and ACAN as well as with Safranin O. In this study, we successfully generated large amounts of hiPSC-derived cartilaginous particles using a combination of tissue engineering techniques. This method is promising as a cartilage regeneration technology with potential for scale-up.

    DOI: 10.1016/j.bbrc.2023.149146

    PubMed

    researchmap

  • Fabrication of shape-designable cartilage from human induced pluripotent stem cell-derived chondroprogenitors using a cell self-aggregation technique. International journal

    Tomoyuki Ota, Tomoka Takao, Ryosuke Iwai, Takeshi Moriwaki, Yohei Kitaguchi, Yuki Fujisawa, Daisuke Yamada, Yoshihiro Kimata, Takeshi Takarada

    Biomedical materials (Bristol, England)   18 ( 6 )   2023.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    With the advancement of tissue engineering technologies, implantable materials have been developed for use in facial plastic surgery, including auriculoplasty and rhinoplasty. Tissue-engineered cartilage comprising only cells and cell-produced extracellular matrix is considered valuable as there is no need to consider problems associated with the absorption of scaffold materials and the generation of immune responses. However, it is exceedingly difficult to produce large-sized complex shapes of cartilage without the use of scaffolds. In this study, we describe the production of shape-designable cartilage using a novel cell self-aggregation technique (CAT) and chondroprogenitor cells derived from human induced pluripotent stem cells as the source. The method described does not require special equipment such as bio-3D printers, and the produced tissue can be induced into well-matured cartilage with abundant cartilage matrix in vitro. Using CAT, we were able to generate cartilage in the form of rings or tubes with adjustable inner diameter and curvature, over a range of several centimeters, without the use of scaffolds. The in vitro fabrication of shape-designable cartilage using CAT will undoubtedly contribute to developments in the field of facial plastic surgery.&#xD.

    DOI: 10.1088/1748-605X/ad02d1

    PubMed

    researchmap

  • A Decellularized Uterine Endometrial Scaffold Enhances Regeneration of the Endometrium in Rats Reviewed International journal

    Yushi Yoshimasa, Tomoka Takao, Satomi Katakura, Shoko Tomisato, Hirotaka Masuda, Mamoru Tanaka, Tetsuo Maruyama

    International Journal of Molecular Sciences   24 ( 8 )   7605 - 7605   2023.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Partial or whole regeneration of the uterine endometrium using extracellular matrix (ECM)-based scaffolds is a therapeutic strategy for uterine infertility due to functional and/or structural endometrial defects. Here, we examined whether the entire endometrium can be regenerated circumferentially using an acellular ECM scaffold (decellularized endometrial scaffold, DES) prepared from rat endometrium. We placed a silicone tube alone to prevent adhesions or a DES loaded with a silicone tube into a recipient uterus in which the endometrium had been surgically removed circumferentially. Histological and immunofluorescent analyses of the uteri one month after tube placement revealed more abundant regenerated endometrial stroma in the uterine horns treated with tube-loaded DES compared to those treated with a tube alone. Luminal and glandular epithelia, however, were not fully recapitulated. These results suggest that DES can enhance the regeneration of endometrial stroma but additional intervention(s) are needed to induce epithelization. Furthermore, the prevention of adhesions alone allowed the endometrial stroma to regenerate circumferentially even without a DES, but to a lesser degree than that with a DES. The use of a DES together with the prevention of adhesions may be beneficial for efficient endometrial regeneration in the uterus that is largely deficient of endometrium.

    DOI: 10.3390/ijms24087605

    PubMed

    researchmap

  • Establishment of a human pluripotent stem cell-derived MKX-td Tomato reporter system Reviewed International journal

    Yuki Fujisawa, Lu Ming, Daisuke Yamada, Tomoka Takao, Takeshi Takarada

    Stem Cell Research & Therapy   13 ( 1 )   515 - 515   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Tendon regeneration is difficult because detailed knowledge about tendon progenitor cells (TPCs), which produce tenocytes to repair tendon tissue, has not been revealed. Mohawk homeobox (MKX) is a marker of TPCs or tenocytes, but a human pluripotent stem cell (hPSC)-based reporter system that visualizes MKX+ cells has not been developed. Here, we established an hPSC-derived MKX-tdTomato reporter cell line and tested the induction ratio of MKX-tdTomato+ cells using our stepwise/xeno-free differentiation protocol. MKX-tdTomato+ cells were generated with high efficiency and expressed tendon-specific markers, including MKX, SCX, TNMD, and COL1A1. Our MKX-tdTomato hPSC line would be a useful tool for studying the development or regeneration of tendon tissue.

    DOI: 10.1186/s13287-022-03203-5

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1186/s13287-022-03203-5/fulltext.html

  • A mediator complex subunit 12 gain-of-function mutation induces partial leiomyoma cell properties in human uterine smooth muscle cells Reviewed International journal

    Tomoka Takao, Masanori Ono, Yushi Yoshimasa, Hirotaka Masuda, Tetsuo Maruyama

    F&S Science   3 ( 3 )   288 - 298   2022.4

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Objective: To clarify whether a mediator complex subunit 12 (MED12) gain-of-function mutation induces leiomyoma cell properties in human uterine smooth muscle cells (USMCs). Design: Experimental study. Setting: Academic research laboratory. Patient(s): Women undergoing hysterectomy for leiomyoma. Intervention(s): CRISPR/Cas9-mediated genome editing to introduce an MED12 gain-of-function mutation (G44D) into human USMCs. Main Outcome Measure(s): Cell proliferation, collagen production, and in vivo tumorigenicity of USMCs with vs. without the MED12 mutation. Result(s): Uterine smooth muscle cells isolated from the uterine myometrium of a 44-year-old patient were subjected to lentiviral vector-mediated gene transduction of the fluorescent protein Venus, followed by long-term passage. Uterine smooth muscle cells with a normal female karyotype, high cell proliferative activity, and Venus expression, but without stem/progenitor cell populations, were obtained and designated as USMC44. Using CRISPR/Cas9-mediated genome editing, mtUSMC44 (MED12, 131G>A, p.G44D) and mock USMC44 without MED12 mutation (wtUSMC44) were established from USMC44. wtUSMC44 and mtUSMC44 showed similar cell proliferation activity, even in the presence of estradiol and progesterone (EP) together with transforming growth factor-beta 3 (TGFB3). In addition, wtUSMC44 and mtUSMC44 generated similar tiny smooth muscle-like tissue constructs when xenotransplanted beneath the kidney capsule in immunodeficient mice treated with EP alone or TGFB3. In contrast, mtUSMC44 produced more collagen type I than wtUSMC in vitro, and this production was likely enhanced by EP and TGFB3. Conclusion(s): The results suggest that the MED12 gain-of-function mutation is involved in collagen production. Although approximately 70% of leiomyomas have MED12 mutations, additional factors and/or events other than MED12 and/or myometrial stem/progenitor cells may be required for fully inducing leiomyoma cell properties, including transformation, in USMCs.

    DOI: 10.1016/j.xfss.2022.04.002

    Scopus

    PubMed

    researchmap

  • Mouse Model for Optogenetic Genome Engineering. Reviewed

    Tomoka Takao, Daisuke Yamada, Takeshi Takarada

    Acta medica Okayama   76 ( 1 )   1 - 5   2022.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Optogenetics, a technology to manipulate biological phenomena thorough light, has attracted much attention in neuroscience. Recently, the Magnet System, a photo-inducible protein dimerization system which can control the intracellular behavior of various biomolecules with high accuracy using light was developed. Furthermore, photoactivation systems for controlling biological phenomena are being developed by combining this technique with genome-editing technology (CRISPR/Cas9 System) or DNA recombination technology (Cre-loxP system). Herein, we review the history of optogenetics and the latest Magnet System technology and introduce our recently developed photoactivatable Cre knock-in mice with temporal-, spatial-, and cell-specific accuracy.

    DOI: 10.18926/AMO/63202

    PubMed

    researchmap

  • Oncogenic potential of human pluripotent stem cell-derived lung organoids with HER2 overexpression. Reviewed International journal

    Akihiro Miura, Daisuke Yamada, Masahiro Nakamura, Shuta Tomida, Dai Shimizu, Yan Jiang, Tomoka Takao, Hiromasa Yamamoto, Ken Suzawa, Kazuhiko Shien, Masaomi Yamane, Masakiyo Sakaguchi, Shinichi Toyooka, Takeshi Takarada

    International journal of cancer   149 ( 8 )   1593 - 1604   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Lung adenocarcinoma (LUAD) is the most common types among lung cancers generally arising from terminal airway and understanding of multistep carcinogenesis is crucial to develop novel therapeutic strategy for LUAD. Here we used human induced pluripotent stem cells (hiPSCs) to establish iHER2-hiPSCs in which doxycycline induced the expression of the oncoprotein human epidermal growth factor receptor 2 (HER2)/ERBB2. Lung progenitors that differentiated from iHER2-hiPSCs, which expressed NKX2-1/TTF-1 known as a lung lineage maker, were cocultured with human fetal fibroblast and formed human lung organoids (HLOs) comprising alveolar type 2-like cells. HLOs that overexpressed HER2 transformed to tumor-like structures similar to atypical adenomatous hyperplasia, which is known for lung precancerous lesion and upregulated the activities of oncogenic signaling cascades such as RAS/RAF/MAPK and PI3K/AKT/mTOR. The degree of morphological irregularity and proliferation capacity were significantly higher in HLOs from iHER2-hiPSCs. Moreover, the transcriptome profile of the HLOs shifted from a normal lung tissue-like state to one characteristic of clinical LUAD with HER2 amplification. Our results suggest that hiPSC-derived HLOs may serve as a model to recapitulate the early tumorigenesis of LUAD and would provide new insights into the molecular basis of tumor initiation and progression.

    DOI: 10.1002/ijc.33713

    PubMed

    researchmap

  • PRRX1 promotes malignant properties in human osteosarcoma Reviewed International journal

    Ryoji Joko, Daisuke Yamada, Masahiro Nakamura, Aki Yoshida, Shota Takihira, Tomoka Takao, Ming Lu, Kohei Sato, Tatsuo Ito, Toshiyuki Kunisada, Eiji Nakata, Toshifumi Ozaki, Takeshi Takarada

    Translational Oncology   14 ( 1 )   100960 - 100960   2021.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Paired related homeobox 1 (PRRX1) is a marker of limb bud mesenchymal cells, and deficiency of p53 or Rb in Prrx1-positive cells induces osteosarcoma in several mouse models. However, the regulatory roles of PRRX1 in human osteosarcoma have not been defined. In this study, we performed PRRX1 immunostaining on 35 human osteosarcoma specimens to assess the correlation between PRRX1 level and overall survival. In patients with osteosarcoma, the expression level of PRRX1 positively correlated with poor prognosis or the ratio of lung metastasis. Additionally, we found PRRX1 expression on in 143B cells, a human osteosarcoma line with a high metastatic capacity. Downregulation of PRRX1 not only suppressed proliferation and invasion but also increased the sensitivity to cisplatin and doxorubicin. When 143B cells were subcutaneously transplanted into nude mice, PRRX1 knockdown decreased tumor sizes and rates of lung metastasis. Interestingly, forskolin, a chemical compound identified by Connectivity Map analysis using RNA expression signatures during PRRX1 knockdown, decreased tumor proliferation and cell migration to the same degree as PRRX1 knockdown. These results demonstrate that PRRX1 promotes tumor malignancy in human osteosarcoma.

    DOI: 10.1016/j.tranon.2020.100960

    PubMed

    researchmap

  • UDP-glucose, a cellular danger signal, and nucleotide receptor P2Y14 enhance the invasion of human extravillous trophoblast cells. Reviewed International journal

    Satomi Katakura 1, Tomoka Takao 1, Toru Arase 2, Yushi Yoshimasa 1, Shoko Tomisato 1, Sayaka Uchida 1, Hirotaka Masuda 1, Hiroshi Uchida 1, Mamoru Tanaka 1, Tetsuo Maruyama

    Placenta   101   194 - 203   2020.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    <h4>Introduction</h4>P2Y14, one of the P2Y purinergic G-protein coupled receptors, is expressed in a variety of cells and tissues. Its ligand, UDP-glucose (UDPG), is released from damaged and stress-stimulated cells and acts as a danger signal via P2Y14. Thus, P2Y14 plays an important role in immunological defense systems. Here, we aimed to elucidate the expression, localization, and role of P2Y14 in human trophoblasts and the placenta.<h4>Methods</h4>Human chorionic villus and placental tissues were subjected to immunostaining for P2Y14 protein and an extravillous trophoblast (EVT) marker, HLA-G. We examined the expression of P2Y14 and the effect of UDPG on cell proliferation and invasion in an EVT cell line, HTR-8/SVneo, using an MTS assay and a Transwell assay, respectively. We tested the effect of UDPG on cell invasion in P2Y14-underexpressing HTR-8/SVneo clones established by the lentiviral introduction of shRNA for P2RY14 mRNA.<h4>Results</h4>Immunostaining revealed that P2Y14 was exclusively expressed by EVTs. P2RY14 mRNA and P2Y14 protein were expressed in HTR-8/SVneo cells. UDPG did not affect cell proliferation but it did enhance invasion. Inhibition of P2Y14 and decreasing the expression of P2Y14 suppressed UDPG-mediated invasive activity.<h4>Conclusions</h4>These results showed that EVT selectively expressed P2Y14 and that P2Y14 was positively involved in UDPG-enhanced EVT invasion. It suggests the possible existence of a danger signal-mediated physiological system at the fetomaternal interface where UDPG released from maternal tissues through destruction by EVT invasion may accelerate EVT invasion, allowing EVTs to undergo successful placentation and vascular remodeling.

    DOI: 10.1016/j.placenta.2020.09.061

    PubMed

    researchmap

  • The orientation of a decellularized uterine scaffold determines the tissue topology and architecture of the regenerated uterus in rats† International journal

    Fumie Miki, Tetsuo Maruyama, Kaoru Miyazaki, Tomoka Takao, Yushi Yoshimasa, Satomi Katakura, Hanako Hihara, Sayaka Uchida, Hirotaka Masuda, Hiroshi Uchida, Toshihiro Nagai, Shinsuke Shibata, Mamoru Tanaka

    Biology of Reproduction   100 ( 5 )   1215 - 1227   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    A decellularized uterine scaffold (DUS) prepared from rats permits recellularization and regeneration of uterine tissues when placed onto a partially excised uterus and supports pregnancy in a fashion comparable to the intact uterus. The underlying extracellular matrix (ECM) together with an acellular, perfusable vascular architecture preserved in DUS is thought to be responsible for appropriate regeneration of the uterus. To investigate this concept, we examined the effect of the orientation of the DUS-preserving ECM and the vascular architecture on uterine regeneration through placement of a DUS onto a partially defective uterine area in the reversed orientation such that the luminal face of the DUS was outside and the serosal face was inside. We characterized the tissue structure and function of the regenerated uterus, comparing the outcome to that when the DUS was placed in the correct orientation. Histological analysis revealed that aberrant structures including ectopic location of glands and an abnormal lining of smooth muscle layers were observed significantly more frequently in the reversed group than in the correct group (70% vs. 30%, P < 0.05). Despite the changes in tissue topology, the uteri regenerated with an incorrectly oriented DUS could achieve pregnancy in a way similar to uteri regenerated with a correctly oriented DUS. These results suggest that DUS-driven ECM orientation determines the regenerated uterus structure. Using DUS in the correct orientation is preferable when clinically applied. The disoriented DUS may deteriorate the tissue topology leading to structural disease of the uterus even though the fertility potential is not immediately affected.

    DOI: 10.1093/biolre/ioz004

    PubMed

    researchmap

  • The orientation of a decellularized uterine scaffold determines the tissue topology and architecture of the regenerated uterus in ratsdagger Reviewed

    F. Miki, T. Maruyama, K. Miyazaki, T. Takao, Y. Yoshimasa, S. Katakura, H. Hihara, S. Uchida, H. Masuda, H. Uchida, T. Nagai, S. Shibata, M. Tanaka

    Biol Reprod   100 ( 5 )   1215 - 1227   2019.5

     More details

    A decellularized uterine scaffold (DUS) prepared from rats permits recellularization and regeneration of uterine tissues when placed onto a partially excised uterus and supports pregnancy in a fashion comparable to the intact uterus. The underlying extracellular matrix (ECM) together with an acellular, perfusable vascular architecture preserved in DUS is thought to be responsible for appropriate regeneration of the uterus. To investigate this concept, we examined the effect of the orientation of the DUS-preserving ECM and the vascular architecture on uterine regeneration through placement of a DUS onto a partially defective uterine area in the reversed orientation such that the luminal face of the DUS was outside and the serosal face was inside. We characterized the tissue structure and function of the regenerated uterus, comparing the outcome to that when the DUS was placed in the correct orientation. Histological analysis revealed that aberrant structures including ectopic location of glands and an abnormal lining of smooth muscle layers were observed significantly more frequently in the reversed group than in the correct group (70% vs. 30%, P &lt; 0.05). Despite the changes in tiss

    DOI: 10.1093/biolre/ioz004

    PubMed

    researchmap

  • Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells. Reviewed International journal

    Kazuo Asanoma 1, Ge Liu 2, Takako Yamane 3, Yoko Miyanari 3, Tomoka Takao 4, Hiroshi Yagi 3, Tatsuhiro Ohgami 3, Akimasa Ichinoe 3, Kenzo Sonoda 3, Norio Wake 2, Kiyoko Kato

    Molecular and cellular biology   35 ( 24 )   4096 - 4109   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Society for Microbiology  

    BHLHE40 and BHLHE41 (BHLHE40/41) are basic helix-loop-helix type transcription factors that play key roles in multiple cell behaviors. BHLHE40/41 were recently shown to be involved in an epithelial-to-mesenchymal transition (EMT). However, the precise mechanism of EMT control by BHLHE40/41 remains unclear. In the present study, we demonstrated that BHLHE40/41 expression was controlled in a pathological stage-dependent manner in human endometrial cancer (HEC). Our<italic>in vitro</italic>assays showed that BHLHE40/41 suppressed tumor cell invasion. BHLHE40/41 also suppressed the transcription of the EMT effectors<italic>SNAI1</italic>,<italic>SNAI2</italic>, and<italic>TWIST1</italic>. We identified the critical promoter regions of<italic>TWIST1</italic>for its basal transcriptional activity. We elucidated that the transcription factor SP1 was involved in the basal transcriptional activity of<italic>TWIST1</italic>and that BHLHE40/41 competed with SP1 for DNA binding to regulate gene transcription. This study is the first to report the detailed functions of BHLHE40 and BHLHE41 in the suppression of EMT effectors<italic>in vitro</italic>. Our results suggest that BHLHE40/41 suppress tumor cell invasion by inhibiting EMT in tumor cells. We propose that BHLHE40/41 are promising markers to predict the aggressiveness of each HEC case and that molecular targeting strategies involving BHLHE40/41 and SP1 may effectively regulate HEC progression.

    DOI: 10.1128/mcb.00678-15

    Web of Science

    PubMed

    researchmap

  • The thermosensitive TRPV3 channel contributes to rapid wound healing in oral epithelia Reviewed International journal

    Reona Aijima, Bing Wang, Tomoka Takao, Hiroshi Mihara, Makiko Kashio, Yasuyoshi Ohsaki, Jing‐Qi Zhang, Atsuko Mizuno, Makoto Suzuki, Yoshio Yamashita, Sadahiko Masuko, Masaaki Goto, Makoto Tominaga, Mizuho A. Kido

    The FASEB Journal   29 ( 1 )   182 - 192   2015.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    The oral cavity provides an entrance to the alimentary tract to serve as a protective barrier against harmful environmental stimuli. The oral mucosa is susceptible to injury because of its location; nonetheless, it has faster wound healing than the skin and less scar formation. However, the molecular pathways regulating this wound healing are unclear. Here, we show that transient receptor potential vanilloid 3 (TRPV3), a thermosensitive Ca(2+)-permeable channel, is more highly expressed in murine oral epithelia than in the skin by quantitative RT-PCR. We found that temperatures above 33°C activated TRPV3 and promoted oral epithelial cell proliferation. The proliferation rate in the oral epithelia of TRPV3 knockout (TRPV3KO) mice was less than that of wild-type (WT) mice. We investigated the contribution of TRPV3 to wound healing using a molar tooth extraction model and found that oral wound closure was delayed in TRPV3KO mice compared with that in WT mice. TRPV3 mRNA was up-regulated in wounded tissues, suggesting that TRPV3 may contribute to oral wound repair. We identified TRPV3 as an essential receptor in heat-induced oral epithelia proliferation and wound healing. Our findings suggest that TRPV3 activation could be a potential therapeutic target for wound healing in skin and oral mucosa.

    DOI: 10.1096/fj.14-251314

    Web of Science

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1096/fj.14-251314

  • Aryl hydrocarbon receptor SNP -130 C/T associates with dioxins susceptibility through regulating its receptor activity and downstream effectors including interleukin 24. Reviewed International journal

    Ge Liu 1, Kazuo Asanoma 2, Tomoka Takao 1, Kiyomi Tsukimori 3, Hiroshi Uchi 4, Masutaka Furue 4, Kiyoko Kato 2, Norio Wake

    Toxicology letters   232 ( 2 )   384 - 392   2014.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Dioxins are persistent environmental pollutants that cause multiple adverse health effects in humans, mainly through binding to the ligand-activated transcription factor, aryl hydrocarbon receptor (AhR). Genetic variation in AhR may modulate the susceptibility to dioxins. In this study, we aimed to evaluate the effects of the single nucleotide polymorphism (SNP) -130 C/T in the AhR promoter on dioxin-inducible gene transcription, and to investigate interleukin-24 (IL-24) and interleukin-1β (IL-1β) as proxies for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure. Using primary human chorionic stromal cells, we found that cells with the TT genotype showed higher AhR mRNA and protein levels than did those of the CC genotype. Microarray was carried out to analyze the gene expression profiles of cells (CC and TT genotype) after exposing the cells to TCDD. Several genes associated with human disorders were more highly up-regulated in cells of the TT genotype. Higher up-regulation of IL-24 and IL-1β mRNA in cells with the TT genotype was observed. Furthermore, blood samples from 64 Yusho patients who were accidentally exposed to high concentrations of dioxins were analyzed for the genotype, dioxins concentrations and serum levels of IL-24 and IL-1β. We observed higher serum IL-24 levels and lower serum IL-1β levels in Yusho patients with the TT genotype than in those with the CC genotype. AhR SNP -130 C/T affects serum IL-24 and IL-1β levels, independently of serum dioxins concentrations in Yusho patients. Our observations demonstrate that SNP -130 C/T modulates AhR expression and expression levels of IL-24 and IL-1β, and suggest an association of AhR SNP -130 C/T with the susceptibility to dioxins.

    DOI: 10.1016/j.toxlet.2014.11.025

    Web of Science

    PubMed

    researchmap

  • Establishment of a new diagnostic method for hydropic villi by using TSSC3 antibody. International journal

    Norio Wake 1, Tomoka Takao, Kazuo Asanoma, Hidenori Kato

    The journal of obstetrics and gynaecology research   39 ( 7 )   1230 - 1235   2013.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    A total of 297 samples of hydropic villi were classified according to DNA polymorphisms as androgenetic moles, dispermic triploids, or biparental diploids. A subset of 267 appropriate samples was included in the study. Most of the macroscopically diagnosed complete mole cases were genetically androgenetic in origin. The partial mole cases consisted of 30 androgenetic moles and 12 dispermic triploids. For the 59 cases macroscopically categorized as hydropic abortion, the genetic analysis revealed 38 androgenetic moles, seven dispermic triploids and 14 biparental diploids. These results showed that a new diagnostic method was required for the management of patients with hydropic villi. We identified the TSSC imprint gene of which expression was shown in normal and partial mole villi but was silenced in complete mole villi. Immunohistochemistry using the TSSC3 antibody demonstrated its efficacy as the differential diagnostic method. TSSC3 play an important role in the differentiation from trophoblast stem cells to progenitors and/or labyrinth trophoblast through the TSSC3/PI3K/Akt/Mash2 signaling pathway.

    DOI: 10.1111/jog.12100

    Web of Science

    PubMed

    researchmap

  • Effect of allergen sensitization on external root resorption Reviewed

    N. Murata, H. Ioi, M. Ouchi, T. Takao, H. Oida, R. Aijima, T. Yamaza, M. A. Kido

    Journal of Dental Research   92 ( 7 )   641 - 647   2013.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    In orthodontic tooth movement (OTM), we should be concerned about external root resorption (ERR) as an undesirable iatrogenic problem, but its mechanisms are not fully understood. Since our previous epidemiologic studies found that patients with allergic diseases showed higher rates of ERR during orthodontic treatment, we explored the possible effect of allergic sensitization on ERR. In ovalbumin (OVA)-sensitized Brown-Norway rats, the amounts of ERR and OTM were greater than those in animals subjected to orthodontic force alone. The expression levels of RANKL and pro-inflammatory cytokines were increased in the periodontal tissues of sensitized rats with OTM, compared with control rats. Furthermore, leukotriene B4 (LTB4), a potent lipid mediator of allergic inflammation, and enzymes of the 5-lipoxygenase pathway, the biosynthetic pathway of leukotrienes, were also up-regulated. We found that low doses of aspirin suppressed ERR in allergen-sensitized rats, as well as the expressions of RANKL, pro-inflammatory cytokines, and LTB4. The present findings indicate that allergen sensitization has adverse effects on ERR under OTM, and that aspirin is a potential therapeutic agent for combating ERR. © International &amp
    American Associations for Dental Research.

    DOI: 10.1177/0022034513488787

    Scopus

    PubMed

    researchmap

  • Oxidative Stress Produced by Xanthine Oxidase Induces Apoptosis in Human Extravillous Trophoblast Cells Reviewed

    Masaharu MURATA, Kotaro FUKUSHIMA, Tomoka TAKAO, Hiroyuki SEKI, Satoru TAKEDA, Norio WAKE

    Journal of Reproduction and Development   59 ( 1 )   7 - 13   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Japanese Society of Animal Reproduction  

    Oxidative stress has been recognized as an important factor in the pathophysiology of preeclampsia. It has been reported that the expression of xanthine oxidase (XO) in the cytotrophoblast and plasma hydrogen peroxide (H2O2) level are significantly higher in preeclamptics than in control women. The aim of this study was to clarify the biological influence of reactive oxygen species (ROS) produced by XO on extravillous trophoblast (EVT) cells. TCL1 cells, a human immortalized EVT cell line, were incubated with xanthine and XO (X/XO). We then measured the cell number, urate level of the culture media and the apoptotic cell ratio. Similar experiments were performed with additional administration of allopurinol, catalase, L-NAME or D-NAME, and with administration of H2O2 in substitution for X/XO. We assessed the effects of H2O2 on invasion ability, tube-like formation and protein expression of HIF1A and ITGAV of TCL1. Finally, the apoptotic cell ratio using primary cultured trophoblasts was measured following exposure to H2O2. X/XO decreased the relative cell number and increased the urate level and apoptotic cell ratio significantly. Elevation of the urate level and apoptotic cell ratio was attenuated by allopurinol and catalase, respectively. L-NAME and D-NAME had no influence on these effects. H2O2 also decreased the relative cell number. Pretreatment with H2O2 significantly inhibited the invasion ability, tube-like formation and HIF1A and ITGAV of TCL1. H2O2 also induced apoptosis in primary cultured trophoblasts. In conclusion, ROS produced by XO induced apoptosis and affected EVT function including invasion and differentiation.

    DOI: 10.1262/jrd.2012-053

    Web of Science

    PubMed

    CiNii Article

    CiNii Books

    researchmap

  • Inhibition of AHR transcription by NF1C is affected by a single-nucleotide polymorphism, and is involved in suppression of human uterine endometrial cancer. Reviewed

    D Li , T Takao, R Tsunematsu, S Morokuma, K Fukushima, H Kobayashi, T Saito, M Furue, N Wake, K Asanoma

    Oncogene   32 ( 41 )   4950 - 4959   2012.12

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Involvement of the aryl hydrocarbon receptor (AHR) in carcinogenesis has been suggested in many studies. Upregulation of AHR has been reported in some cancer species, and an association between single-nucleotide polymorphisms (SNPs) of AHR and cancer risk or cancer development has also been reported. This evidence suggests the involvement of some specific SNPs in AHR transcriptional regulation in the process of carcinogenesis or cancer development, but there have been no studies to elucidate the mechanism involved. In this study, we identified the transcription factor Nuclear Factor 1-C (NF1C) as a candidate to regulate AHR transcription in a polymorphism-dependent manner. SNP rs10249788 was included in a consensus binding site for NF1C. Our results suggested that NF1C preferred the C allele to the T allele at rs10249788 for binding. Forced expression of NF1C suppressed the activity of the AHR promoter with C at rs10249788 stronger than that with T. Moreover, expression analysis of human uterine endometrial cancer (HEC) specimens showed greater upregulation of AHR and downregulation of NF1C than those of normal endometrium specimens. Sequence analysis showed HEC patients at advanced stages tended to possess T/T alleles more frequently than healthy women. We also demonstrated that NF1C suppressed proliferation, motility and invasion of HEC cells. This function was at least partially mediated by AHR. This study is the first to report that a polymorphism on the AHR regulatory region affected transcriptional regulation of the AHR gene in vitro. Because NF1C is a tumor suppressor, our new insights into AHR deregulation and its polymorphisms could reveal novel mechanisms of genetic susceptibility to cancer.

    DOI: 10.1038/onc.2012.509

    Web of Science

    PubMed

    researchmap

    Other Link: http://www.nature.com/articles/onc2012509

  • The maternally expressed gene Tssc3 regulates the expression of MASH2 transcription factor in mouse trophoblast stem cells through the AKT-Sp1 signaling pathway. Reviewed International journal

    Tomoka Takao 1, Kazuo Asanoma, Ryosuke Tsunematsu, Kiyoko Kato, Norio Wake

    The Journal of biological chemistry   287 ( 51 )   42685 - 42694   2012.10

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Tssc3 is a maternally expressed/paternally silenced imprinted gene. Recent evidence suggests that the loss of TSSC3 results in placental overgrowth in mice. These findings showed that the TSSC3 gene functions as a negative regulator of placental growth. In this study, we describe the function of TSSC3 and its signaling pathway in mouse trophoblast stem (TS) cell differentiation. First of all, we tested Tssc3 expression levels in TS cells. TS cells expressed Tssc3, and its expression level was the highest from day 1 to 4 but was down-regulated at day 5 after the induction of differentiation. Overexpression of TSSC3 in TS cells up-regulated Gcm1 and Mash2, which are marker genes of mouse trophoblast differentiation. Down-regulation of TSSC3 by siRNA enhanced Pl1 and Tpbpa expression in TS cells cultured under stem cell conditions, suggesting the contribution of TSSC3 to the differentiation from TS to trophoblast progenitors and/or labyrinth trophoblasts. TSSC3 activated the PI3K/AKT pathway through binding with phosphatidylinositol phosphate lipids and enhanced the activity of a promoter containing an E-box structure, which is the binding sequence of the Mash2 downstream target gene promoter. PI3K inhibitor suppressed the promoter activity induced by TSSC3. TSSC3 induced Sp1 translocation from cytoplasm to nucleus through the PI3K/AKT pathway. Nuclear Sp1 activated the Mash2 transcription by Sp1 binding with a consensus Sp1-binding motif. This is the first report describing that TSSC3 plays an important role in the differentiation from TS to trophoblast progenitors and/or labyrinth trophoblasts through the TSSC3/PI3K/AKT/MASH2 signaling pathway.

    DOI: 10.1074/jbc.m112.388777

    Web of Science

    PubMed

    researchmap

  • Effect of transient TCDD exposure on immortalized human trophoblast-derived cell lines Reviewed

    K. Fukushima, K. Tsukimori, D. Li, T. Takao, S. Morokuma, K. Kato, H. Seki, S. Takeda, S. Matsumura, N. Wake

    HUMAN & EXPERIMENTAL TOXICOLOGY   31 ( 6 )   550 - 556   2012.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SAGE PUBLICATIONS LTD  

    Low level, antenatal exposure to dioxins is associated with low birth weight, which in turn is associated with long-term sequelae. We exposed the human extravillous cytotrophoblast (EVT) lines HTR-8/SV40 and TCLI to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and assessed cell growth, invasion, and differentiation. TCDD had no effect on cell proliferation, invasion, or tube formation in Matrigel. The EVT-derived cells expressed a functional aryl hydrocarbon receptor protein; however, TCDD exposure did not alter expression levels of proteins involved in EVT differentiation in early pregnancy, including hypoxia-inducible factor IA (HIFIA), vascular endothelial growth factor (VEGF), Integrin AI, A6, and AVB3. These results suggest that the reduction in fetal weight induced by dioxin is not the result of vascular remodeling via EVT dysfunction.

    DOI: 10.1177/0960327111424305

    Web of Science

    PubMed

    researchmap

  • Isolation and characterization of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line. Reviewed International journal

    Tomoka Takao, Kazuo Asanoma, Kiyoko Kato, Kotaro Fukushima, Ryosuke Tsunematsu, Toshio Hirakawa, Sueo Matsumura, Hiroyuki Seki, Satoru Takeda, Norio Wake

    PloS one   6 ( 7 )   e21990 - e21990   2011.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Public Library of Science (PLoS)  

    Recently, numerous studies have identified that immature cell populations including stem cells and progenitor cells can be found among "side-population" (SP) cells. Although SP cells isolated from some adult tissues have been reported elsewhere, isolation and characterization of human trophoblast SP remained to be reported. In this study, HTR-8/SVneo cells and human primary villous cytotrophoblasts (vCTBs) were stained with Hoechst 33342 and SP and non-SP (NSP) fractions were isolated using a cell sorter. A small population of SP cells was identified in HTR-8/SVneo cells and in vCTBs. SP cells expressed several vCTB-specific markers and failed to express syncytiotrophoblast (STB) or extravillous cytotrophopblast (EVT)-specific differentiation markers. SP cells formed colonies and proliferated on mouse embryonic fibroblast (MEF) feeder cells or in MEF conditioned medium supplemented with heparin/FGF2, and they also showed long-term repopulating property. SP cells could differentiate into both STB and EVT cell lineages and expressed several differentiation markers. Microarray analysis revealed that IL7R and IL1R2 were exclusively expressed in SP cells and not in NSP cells. vCTB cells sorted as positive for both IL7R and IL1R2 failed to express trophoblast differentiation markers and spontaneously differentiated into both STB and EVT in basal medium. These features shown by the SP cells suggested that IL7R and IL1R2 are available as markers to detect the SP cells and that vCTB progenitor cells and trophoblast stem cells were involved in the SP cell population.

    DOI: 10.1371/journal.pone.0021990

    Web of Science

    PubMed

    researchmap

  • Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response. Reviewed International journal

    Kato K, Kuhara A, Yoneda T, Inoue T, Takao T, Ohgami T, Dan L, Kuboyama A, Kusunoki S, Takeda S, Wake N.

    Molecular cancer therapeutics   10 ( 8 )   1430 - 1439   2011.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Association for Cancer Research (AACR)  

    We previously isolated side-population (SP) cells from a human endometrial cancer cell line, Hec1, and determined that Hec1-SP cells have cancer stem-like cell features. In this study, we isolated SP cells and non-SP (NSP) cells derived from a rat endometrial cell line expressing human [(12)Val] KRAS (RK12V cells) and determined the SP phenotype. RK12V-SP cells showed self-renewal capacity, the potential to develop into stromal cells, reduced expression levels of differentiation markers, long-term proliferating capacity in cultures, and enhanced tumorigenicity, indicating that RK12V-SP cells have cancer stem-like cell features. RK12V-SP cells also display higher resistance to conventional chemotherapeutic drugs. In contrast, treatment with a histone deacetylases (HDAC) inhibitor, sodium butyrate (NaB), reduced self-renewal capacity and completely suppressed colony formation of RK12V-SP cells in a soft agar. The levels of intracellular reactive oxygen species (ROS) and the number of γH2AX foci were increased by NaB treatment of both RK12V-SP cells and RK12V-NSP cells. The expression levels of γH2AX, p21, p27, and phospho-p38 mitogen-activated protein kinase were enhanced in RK12V-SP cells compared with RK12V-NSP cells. These results imply that treatment with NaB induced production of intracellular ROS and DNA damage in both RK12V-SP and RK12V-NSP cells. Following NaB treatment, DNA damage response signals were enhanced more in RK12V-SP cells than in RK12V-NSP cells. This is the first article on an inhibitory effect of NaB on proliferation of endometrial cancer stem-like cells. HDAC inhibitors may represent an attractive antitumor therapy based upon their inhibitory effects on cancer stem-like cells.

    DOI: 10.1158/1535-7163.mct-10-1062

    DOI: 10.1158/1535-7163.MCT-10-1062

    Web of Science

    PubMed

    researchmap

  • Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Reviewed International journal

    Kiyoko Kato 1, Tomoka Takao, Ayumi Kuboyama, Yoshihiro Tanaka, Tatsuhiro Ohgami, Shinichiro Yamaguchi, Sawako Adachi, Tomoko Yoneda, Yousuke Ueoka, Keiji Kato, Shinichi Hayashi, Kazuo Asanoma, Norio Wake

    The American journal of pathology   176 ( 1 )   381 - 392   2009.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Cancer stem-like cell subpopulations, referred to as "side-population" (SP) cells, have been identified in several tumors based on their ability to efflux the fluorescent dye Hoechst 33342. Although SP cells have been identified in the normal human endometrium and endometrial cancer, little is known about their characteristics. In this study, we isolated and characterized the SP cells in human endometrial cancer cells and in rat endometrial cells expressing oncogenic human K-Ras protein. These SP cells showed i) reduction in the expression levels of differentiation markers; ii) long-term proliferative capacity of the cell cultures; iii) self-renewal capacity in vitro; iv) enhancement of migration, lamellipodia, and uropodia formation; and v) enhanced tumorigenicity. In nude mice, SP cells formed large, invasive tumors, which were composed of both tumor cells and stromal-like cells with enriched extracellular matrix. The expression levels of vimentin, alpha-smooth muscle actin, and collagen III were enhanced in SP tumors compared with the levels in non-SP tumors. In addition, analysis of microdissected samples and fluorescence in situ hybridization of Hec1-SP-tumors showed that the stromal-like cells with enriched extracellular matrix contained human DNA, confirming that the stromal-like cells were derived from the inoculated cells. Moreober, in a Matrigel assay, SP cells differentiated into alpha-smooth muscle actin-expressing cells. These findings demonstrate that SP cells have cancer stem-like cell features, including the potential to differentiate into the mesenchymal cell lineage.

    DOI: 10.2353/ajpath.2010.090056

    Web of Science

    PubMed

    researchmap

  • TRPV2 expression in rat oral mucosa Reviewed International journal

    Daiji Shimohira, Mizuho A. Kido, Atsushi Danjo, Tomoka Takao, Bing Wang, Jing-Qi Zhang, Takayoshi Yamaza, Sadahiko Masuko, Masaaki Goto, Teruo Tanaka

    Histochemistry and Cell Biology   132 ( 4 )   423 - 433   2009.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    The oral mucosa is a highly specialised, stratified epithelium that confers protection from infection and physical, chemical and thermal stimuli. The non-keratinised junctional epithelium surrounds each tooth like a collar and is easily attacked by foreign substances from the oral sulcus. We found that TRPV2, a temperature-gated channel, is highly expressed in junctional epithelial cells, but not in oral sulcular epithelial cells or oral epithelial cells. Dual or triple immunolabelling with immunocompetent cell markers also revealed TRPV2 expression in Langerhans cells and in dendritic cells and macrophages. Electron microscopy disclosed TRPV2 immunoreactivity in the unmyelinated and thinly myelinated axons within the connective tissue underlying the epithelium. TRPV2 labelling was also observed in venule endothelial cells. The electron-dense immunoreaction in junctional epithelial cells, macrophages and neural axons occurred on the plasma membrane, on invaginations of the plasma membrane and in vesicular structures. Because TRPV2 has been shown to respond to temperature, hypotonicity and mechanical stimuli, gingival cells expressing TRPV2 may act as sensor cells, detecting changes in the physical and chemical environment, and may play a role in subsequent defence mechanisms.

    DOI: 10.1007/s00418-009-0616-y

    Web of Science

    PubMed

    researchmap

    Other Link: http://link.springer.com/article/10.1007/s00418-009-0616-y/fulltext.html

  • Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor. Reviewed International journal

    Shinichiro Yamaguchi , Kazuo Asanoma, Tomoka Takao, Kiyoko Kato, Norio Wake

    International journal of cancer   124 ( 11 )   2577 - 2588   2009.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    HOPX (homeodomain only protein X) is a newly identified homeobox gene whose loss of expression has been reported for several types of neoplasm. Although we found most human uterine endometrial cancers (HEC) defective in HOPX expression, genetic mutations in the HOPX gene were undetectable. As is the case with several tumor suppressor genes, the promoter region of HOPX is densely methylated in HEC tissue samples obtained by laser capture microdissection. HOPX mRNA and protein levels were reduced in the majority of samples, and this correlated with hypermethylation of the HOPX promoter. Forced expression of HOPX resulted in a partial block in cell proliferation, in vivo tumorigenicity and c-fos gene expression in HEC and MCF7 cells in response to 17beta-estradiol (E(2)) stimulation. Analysis of the serum response element (SRE) of c-fos gene promoter showed that the effect of HOPX expression is associated with inhibition of E(2)-induced c-fos activation through the serum response factor (SRF) motif. Knockdown of HOPX in immortalized human endometrial cells resulted in accelerated proliferation. Our study indicates that transcriptional silencing of HOPX results from hypermethylation of the HOPpromoter, which leads to HEC development.

    DOI: 10.1002/ijc.24217

    Web of Science

    PubMed

    researchmap

▼display all

MISC

  • 悪性末梢神経鞘腫瘍における悪性化を促進する新規メカニズム 転写因子PRRX1とTOP2Aのタンパク質間相互作用の発見

    たき平 将太, 山田 大祐, 大曽根 達則, 高尾 知佳, 板野 拓人, 藤原 智洋, 中田 英二, 国定 俊之, 尾崎 敏文, 宝田 剛志

    日本整形外科学会雑誌   98 ( 8 )   S1957 - S1957   2024.9

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 悪性末梢神経鞘腫瘍におけるPRRX1とTOP2Aの相互作用による悪性化メカニズムの新規解明

    たき平 将太, 中田 英二, 板野 拓人, 藤原 智洋, 国定 俊之, 大曽根 達則, 山田 大祐, 高尾 知佳, 宝田 剛志, 尾崎 敏文

    日本整形外科学会雑誌   98 ( 6 )   S1529 - S1529   2024.6

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • ヒトiPS細胞由来軟骨組織を利用した小児気管疾患に対する再生治療法の開発

    花木 祥二朗, 高尾 知佳, 藤澤 佑樹, 山田 大祐, 岩井 良輔, 宝田 剛志

    日本小児外科学会雑誌   60 ( 3 )   509 - 509   2024.4

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • Development of Regenerative Therapy for Pediatric Tracheal Disorders using Human iPSC-Derived Cartilage Tissue

    花木祥二朗, 花木祥二朗, 高尾知佳, 藤澤佑樹, 山田大祐, 岩井良輔, 宝田剛志

    日本小児外科学会雑誌   60 ( 3 )   509 - 509   2024.4

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 悪性末梢神経鞘腫瘍において転写因子PRRX1はTOP2Aと相互作用し悪性化を促進させる

    たき平 将太, 中田 英二, 板野 拓人, 藤原 智洋, 国定 俊之, 大曽根 達則, 山田 大祐, 高尾 知佳, 宝田 剛志, 尾崎 敏文

    日本整形外科学会雑誌   98 ( 2 )   S76 - S76   2024.3

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • 悪性末梢神経鞘腫瘍において転写因子PRRX1はTOP2Aと相互作用し悪性化を促進させる

    たき平 将太, 中田 英二, 板野 拓人, 藤原 智洋, 国定 俊之, 大曽根 達則, 山田 大祐, 高尾 知佳, 宝田 剛志, 尾崎 敏文

    日本整形外科学会雑誌   98 ( 2 )   S76 - S76   2024.3

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    J-GLOBAL

    researchmap

  • ヒトiPS細胞由来肢芽間葉系細胞を用いた四肢形成機序の検討 Reviewed

    髙尾知佳, 大曽根達則, 山田大祐, 中田英二, 尾﨑 敏文, 宝田剛志

    日本軟骨代謝学会プログラム・抄録集 36th 2024年   2024.2

     More details

    Authorship:Lead author  

    researchmap

  • 神経線維腫症1型患者由来ヒトiPS細胞株の樹立

    大澤 太郎, 中田 英二, 岡本 真幸, 山田 大祐, 二川 摩周, 高尾 知佳, 平沢 晃, 尾崎 敏文, 宝田 剛志

    日本レックリングハウゼン病学会学術大会プログラム・抄録集   15回   24 - 24   2024.2

     More details

    Language:Japanese   Publisher:日本レックリングハウゼン病学会  

    J-GLOBAL

    researchmap

  • ヒトiPS細胞由来肢芽間葉系細胞を用いたヒト肢芽発生機序の検討

    高尾知佳, 大曽根達則, 山田大祐, 中田英二, 尾崎敏文, 宝田剛志

    日本再生医療学会総会(Web)   23rd   2024

  • ヒトiPS細胞由来肢芽間葉系細胞から作製した軟骨組織体を用いた骨再生

    中田 英二, 佐藤 浩平, 高尾 知佳, 藤澤 祐樹, 山田 大祐, 上原 健敬, 藤原 智洋, 尾崎 敏文, 宝田 剛志

    移植   58 ( 3 )   293 - 293   2023.12

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • ヒトiPS細胞由来肢芽間葉系細胞の発生機序の検討

    高尾 知佳, 大曽根 達則, 山田 大祐, 中田 英二, 尾崎 敏文, 宝田 剛志

    日本整形外科学会雑誌   97 ( 8 )   S1599 - S1599   2023.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    J-GLOBAL

    researchmap

  • 悪性末梢神経鞘腫瘍におけるPRRX1の悪性化因子としての役割

    たき平 将太, 中田 英二, 板野 拓人, 片山 晴喜, 藤原 智洋, 国定 俊之, 山田 大祐, 高尾 知佳, 宝田 剛志, 尾崎 敏文

    日本整形外科学会雑誌   97 ( 8 )   S1890 - S1890   2023.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • ヒトiPS細胞由来肢芽間葉系細胞を用いた骨再建法の開発

    佐藤 浩平, 高尾 知佳, 中田 英二, 藤澤 佑樹, 山田 大祐, 上原 健敬, 藤原 智洋, 依光 正則, 国定 俊之, 尾崎 敏文, 宝田 剛志

    日本整形外科学会雑誌   97 ( 8 )   S1868 - S1868   2023.8

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    J-GLOBAL

    researchmap

  • 悪性末梢神経鞘腫瘍における治療標的PRRX1の同定と新規創薬開発の可能性

    たき平 将太, 山田 大祐, 岡本 真幸, 高尾 知佳, 中田 英二, 板野 拓人, 藤原 智洋, 国定 俊之, 尾崎 敏文, 宝田 剛志

    日本整形外科学会雑誌   97 ( 6 )   S1428 - S1428   2023.6

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    J-GLOBAL

    researchmap

  • ヒトiPS細胞から誘導した肢芽間葉系細胞による軟骨シートの作製

    藤澤 佑樹, 高尾 知佳, 佐藤 正人, 豊田 恵利子, 山田 大祐, 中田 英二, 尾崎 敏文, 宝田 剛志

    移植   57 ( 4 )   362 - 362   2023.4

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • ヒト多能性幹細胞から誘導した肢芽間葉系細胞と、その拡大培養法の開発

    中田 英二, 山田 大祐, 高尾 知佳, たき平 将太, 藤原 智洋, 尾崎 敏文, 宝田 剛志

    移植   57 ( 4 )   363 - 363   2023.4

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • 悪性末梢神経鞘腫瘍におけるPRRX1の治療標的分子としての可能性

    たき平 将太, 中田 英二, 大曽根 達則, 山田 大祐, 高尾 知佳, 佐藤 浩平, 畑 利彰, 藤原 智洋, 国定 俊之, 宝田 剛志, 尾崎 敏文

    日本整形外科学会雑誌   97 ( 3 )   S1040 - S1040   2023.3

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • The roles of PRRX1 in malignant peripheral nerve sheath tumor

    たき平将太, 中田英二, 山田大祐, 片山晴喜, 畑利彰, 藤原智洋, 高尾知佳, 国定俊之, 宝田剛志, 尾崎敏文

    日本レックリングハウゼン病学会学術大会プログラム・抄録集(CD-ROM)   14回 ( 8 )   16 - 16   2023.2

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 細胞自己凝集化技術とヒトiPS細胞由来肢芽間葉系細胞を組み合わせた形状型軟骨組織体の作製

    藤澤佑樹, 太田智之, 太田智之, 高尾知佳, 北口陽平, 北口陽平, 山田大祐, 岩井良輔, 木股敬裕, 宝田剛志

    日本再生医療学会総会(Web)   22nd   2023

  • ヒトiPS細胞から誘導した肢芽間葉系細胞による軟骨シートの開発

    高尾知佳, 佐藤正人, 豊田恵利子, 藤澤佑樹, 山田大祐, 中田英二, 尾崎敏文, 宝田剛志

    日本再生医療学会総会(Web)   22nd   2023

  • ヒト多能性幹細胞由来肢芽間葉系細胞を用いた軟骨分化誘導技術の開発

    山田大祐, 高尾知佳, 中村正裕, 戸口田淳也, 宝田剛志

    日本再生医療学会総会(Web)   22nd   2023

  • Development of an Endochondral Ossification Suppression Method using no glucose medium

    北口陽平, 北口陽平, 太田智之, 太田智之, 高尾知佳, 岩井良輔, 藤澤祐樹, 山田大祐, 大曽根達則, 木股敬裕, 宝田剛志

    日本軟骨代謝学会プログラム・抄録集   35th   2023

  • 無糖培地による培養軟骨移植時の内軟骨性骨化抑制法の開発

    北口陽平, 太田智之, 高尾知佳, 岩井良輔, 山田大祐, 大曽根達則, 木股敬裕, 宝田剛志

    日本形成外科学会総会・学術集会プログラム・抄録集   66th   2023

  • Disease modeling and high-throughput screening using disease-specific human iPSC-derived limb bud mesenchymal cells

    山田大祐, 高尾知佳, 藤澤祐樹, 戸口田淳也, 宝田剛志

    日本軟骨代謝学会プログラム・抄録集   35th   2023

  • Production of chondrocyte sheet using human induced pluripotent stem cell-derived limb bud mesenchymal cells

    高尾知佳, 佐藤正人, 豊田恵利子, 藤澤佑樹, 山田大祐, 中田英二, 尾崎敏文, 宝田剛志

    日本軟骨代謝学会プログラム・抄録集   35th   2023

  • 関節軟骨再生を指向したヒトiPS細胞に由来する板状軟骨組織体の開発

    藤澤佑樹, たき平将太, たき平将太, 高尾知佳, 山田大祐, 太田智之, 太田智之, 北口陽平, 北口陽平, 岩井良輔, 中田英二, 木股敬裕, 尾崎敏文, 宝田剛志

    日本整形外科学会雑誌   97 ( 8 )   S1662 - S1662   2023

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    J-GLOBAL

    researchmap

  • Fabrication of scaffold-free tissue-engineered cartilage tissues from human iPS cell-derived limb bud mesenchymal cells with cell-self aggregation technique

    藤澤佑樹, 高尾知佳, 太田智之, 北口陽平, たき平将太, 岩井良輔, 山田大祐, 木股敬裕, 宝田剛志

    組織培養研究(Web)   41 ( 2 )   2023

  • Bone regeneration using cartilage tissue by human iPS cell-derived limb bud mesenchymal cells

    中田英二, 佐藤浩平, 高尾知佳, 藤澤祐樹, 山田大祐, 上原健敬, 藤原智洋, 尾崎敏文, 宝田剛志

    移植(Web)   58 ( 3 )   2023

  • 悪性末梢神経鞘腫瘍におけるPRRX1の悪性化因子としての役割

    たき平 将太, 山田 大祐, 高尾 知佳, 中田 英二, 近藤 宏也, 佐藤 浩平, 畑 利彰, 藤原 智洋, 国定 俊之, 尾崎 敏文, 宝田 剛志

    日本整形外科学会雑誌   96 ( 8 )   S1768 - S1768   2022.9

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • ヒトiPS細胞来肢芽間葉系細胞を用いた硝子軟骨シートの作製

    高尾 知佳, 佐藤 正人, 豊田 恵利子, 山田 大祐, 中田 英二, 尾崎 敏文, 宝田 剛志

    日本整形外科学会雑誌   96 ( 8 )   S1557 - S1557   2022.9

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    researchmap

  • Induction and stable expansion of human pluripotent stem cell-derived limb bud-mesenchymal cells

    山田大祐, 高尾知佳, 中村正裕, MING Lu, 戸口田淳也, 宝田剛志

    日本軟骨代謝学会プログラム・抄録集   34th   2022

  • Dissecting the heterogeneity of Prrx1-positive cells during limb development by single-cell RNA sequencing analysis

    高尾知佳, 中村正裕, MING Lu, 山田大祐, 北條宏徳, 宝田剛志

    日本軟骨代謝学会プログラム・抄録集   34th   2022

  • Preparation of scaffold-free tissue-engineered 3D cartilage construct for application in facial plastic surgery

    太田智之, 太田智之, 高尾知佳, 岩井良輔, 山田大祐, 北口陽平, 北口陽平, 木股敬裕, 宝田剛志

    日本軟骨代謝学会プログラム・抄録集   34th   2022

  • 自己凝集化技術を応用した形状型スキャフォールドフリー三次元培養軟骨の開発

    太田智之, 太田智之, 高尾知佳, 岩井良輔, 山田大祐, 北口陽平, 北口陽平, 森脇健司, 中村正裕, 大曽根達則, 木股敬裕, 宝田剛志

    日本形成外科学会基礎学術集会プログラム・抄録集   31st   2022

  • 形成外科領域における細胞自己凝集化技術を用いたスキャフォールドフリー三次元軟骨培養法の開発

    北口陽平, 北口陽平, 北口陽平, 太田智之, 太田智之, 高尾知佳, 岩井良輔, 山田大祐, 藤澤祐樹, 大曽根達則, 森脇健司, 中村正裕, 木股敬裕, 宝田剛志

    日本形成外科学会基礎学術集会プログラム・抄録集   31st   2022

  • ヒトiPS細胞から誘導した肢芽間葉系細胞による軟骨シートの作製

    藤澤佑樹, 高尾知佳, 佐藤正人, 豊田恵利子, 山田大祐, 中田英二, 尾崎敏文, 宝田剛志

    移植(Web)   57 ( 4 )   2022

  • ヒト多能性幹細胞から誘導した肢芽間葉系細胞と,その拡大培養法の開発

    中田英二, 山田大祐, 高尾知佳, たき平将太, たき平将太, 藤原智洋, 尾崎敏文, 宝田剛志

    移植(Web)   57 ( 4 )   2022

  • マウス骨髄内LepR陽性細胞中の細胞不均一性の解析

    高尾知佳, 中村正裕, 山田大祐, 宝田剛志

    日本骨形態計測学会雑誌   32 ( 1 )   S180 - S180   2022

     More details

    Language:Japanese   Publisher:日本骨形態計測学会  

    J-GLOBAL

    researchmap

  • 子宮内膜脱細胞化骨格による子宮内膜の全層欠損の修復・再生の試み

    吉政佑之, 吉政佑之, 丸山哲夫, 高尾知佳, 升田博隆, 片倉慧美, 富里祥子, 内田明花, 内田浩, 田中守

    日本生殖医学会雑誌   67 ( 4 )   321 - 321   2022

     More details

    Language:Japanese   Publisher:(一社)日本生殖医学会  

    J-GLOBAL

    researchmap

  • ヒトiPS細胞由来肢芽間葉系細胞から作製した軟骨組織体を用いた骨再生研究

    佐藤浩平, 佐藤浩平, 高尾知佳, 藤澤祐樹, 山田大祐, 上原健敬, 依光正則, 中田英二, 尾崎敏文, 宝田剛志

    整形外科バイオマテリアル研究会プログラム・抄録集   41st   2022

  • Establishment of high-throughput drug screening system using human limb bud mesenchymal cells derived from skeletal dysplasia specific iPSC

    Yamada Daisuke, Takao Tomoka, Nakamura Masahiro, Ming Lu, Toguchida Junya, Takarada Takeshi

    Proceedings for Annual Meeting of The Japanese Pharmacological Society   95   2-O-087   2022

     More details

    Language:Japanese   Publisher:Japanese Pharmacological Society  

    [Background] To achieve the disease modeling of skeletal dysplasia, human induced pluripotent stem cells (iPSCs) will be useful but the induction method for limb bud mesenchymal (LBM) cells, which can give rise to most of the future limb elements - bone, cartilage and tendon/ligament, has not been established. In this study, we developed the induction and expansion protocol of LBM cells from human iPSCs, and a high-throughput drug screening system using human LBM cells differentiated from iPSC which is derived from patients with skeletal dysplasia.

    [Method] Paired-related homeobox 1 (PRRX1) serves as a marker for the LBM. To assess the induction efficiency of PRRX1 positive cells during each differentiation step, we established PRRX1-tdTomato reporter human iPSC line. Lateral plate mesoderm cells (LPM) derived from PRRX1-tdTomato reporter were used to establish the LBM-inducing method that recapitulates human developmental process. The chondrogenic capacity of expandable LBM (ExpLBM) cells was assessed using our two- or three- dimensional chondrogenic induction method (2DCI or 3DCI). In addition, ExpLBM cells differentiated from iPSCs derived from patients with type II collagenopathy (COL2pathy), one of the skeletal dysplasia arising from mutations in COL2A1, were used to develop high-throughput screening system.

    [Results] By activating WNT signaling and inhibiting BMP/TGFb/headge hog signaling pathways, almost all LPM cells could be induced to PRRX1 positive LBM cells. Interestingly, we found the defined culture method that can not only stably expand LBM cells (ExpLBM) but also maintain their PRRX1 expression. ExpLBM formed Alcian Blue positive nodules under 2DCI condition and Safranin O positive cartilaginous particles under 3DCI condition. 2DCI-based high-throughput screening system found that several chemicals improved the chondrogenic capacity of ExpLBM derived from COL2pathy patient.

    [Conclusion] ExpLBM cells will be a potential tool to study human bone development, cartilage regeneration and drug discovery using disease-specific human iPSCs.

    DOI: 10.1254/jpssuppl.95.0_2-o-087

    researchmap

  • 子宮内膜症病巣における幹細胞マーカーSUSD2/W5C5陽性細胞の同定とその幹細胞特性の解析

    富里 祥子, 丸山 哲夫, 高尾 知佳, 片倉 慧美, 吉政 佑之, 内田 明花, 内田 浩, 升田 博隆, 田中 守, 甲賀 かをり, 大須賀 穣

    日本生殖医学会雑誌   66 ( 4 )   315 - 315   2021.10

     More details

    Language:Japanese   Publisher:(一社)日本生殖医学会  

    J-GLOBAL

    researchmap

  • ヒト多能性幹細胞からの軟骨前駆細胞の誘導と,その拡大培養方法の開発

    山田大祐, 高尾知佳, 中村正裕, 戸口田淳也, 宝田剛志

    日本整形外科学会雑誌   95 ( 8 )   S1481 - S1481   2021

     More details

    Language:Japanese   Publisher:(公社)日本整形外科学会  

    J-GLOBAL

    researchmap

  • ヒト多能性幹細胞由来軟骨前駆細胞を用いた硝子軟骨組織作製技術の開発

    明ろ, 山田大祐, 高尾知佳, 戸口田淳也, 宝田剛志

    日本骨代謝学会学術集会プログラム抄録集(CD-ROM)   39th   137 - 137   2021

     More details

    Language:Japanese   Publisher:(一社)日本骨代謝学会  

    J-GLOBAL

    researchmap

  • マウス四肢骨格発生過程の一細胞遺伝子発現解析

    高尾知佳, 明ろ, 山田大祐, 北條宏徳, 宝田剛志

    日本骨代謝学会学術集会プログラム抄録集(CD-ROM)   39th   146 - 146   2021

     More details

    Language:Japanese   Publisher:(一社)日本骨代謝学会  

    J-GLOBAL

    researchmap

  • Heterogeneity and its hierarchy of Prrx1-positive cells during limb development

    中井結希, 高尾知佳, 中村正祐, MING Lu, 山田大祐, 宝田剛志

    日本分子生物学会年会プログラム・要旨集(Web)   44th   2021

  • 探し求められていた胎盤の栄養膜幹細胞~治療応用への可能性~

    高尾知佳

    生物工学会誌   99 ( 1 )   34 - 34   2021

  • Development of tTA-dependent photoactivatable Cre recombinase knock-in mouse

    高尾知佳, 宝田剛志

    生化学   93 ( 3 )   414 - 419   2021

  • 光応答性CRISPR/Cas9システムを用いたマウス子宮における胚着床のin vivo制御

    高尾知佳, 高尾知佳, 升田博隆, 佐藤守俊, 丸山哲夫

    日本生殖内分泌学会雑誌(Web)   25   17 - 20   2020

     More details

    Language:Japanese   Publisher:日本生殖内分泌学会  

    光応答性CRISPR/Cas9システムが実際にCas9として機能するのか、マウス胚着床を制御することが可能かについて検討した。子宮体癌細胞株Ishikawa(IK)細胞に上皮マーカーであるEpCAMプロモーターEp-Prを挿入したLuciferase誘導細胞株としてIK-Ep-Pr細胞を作製し、このEpCAMプロモーターに対し特異的なsgRNA(sgProm)と対照群のコントロールsgRNA(sgCtrl)を作製した。腫瘍内および腹腔内両者ともにLuciferase活性が抑制されていることが確認され、in vitroおよびin vivoともに光Cas9が機能することが明らかとなった。さらに、光Cas9で制御される胚着床モデルの作製を行った。4.5日目のマウス子宮を調べた結果、妊娠コントロール群で強いleukemia inhibitory factor(LIF)発現が認められたが、LED照射を行ったノックアウト群ではLIFの発現が減少していた。7.5日目のマウス子宮内胎児数では、妊娠コントロール群に比較してノックアウト群ではその数が有意に減少していた。光Cas9を用いてin vivo胚着床モデルの作製が可能となった。

    J-GLOBAL

    researchmap

  • Identification of candidate drugs targeting human endometrial cancer stem cells

    MARUYAMA Tetsuo, TAKAO Tomoka, MASUDA Hirotaka, MIKI Fumie, KATAKURA Satomi, TOMISATO Shoko, YOSHIMASA Yushi, UCHIDA Sayaka, UCHIDA Hiroshi, TANAKA Mamoru, AOKI Daisuke

    日本産科婦人科学会雑誌   71   2019

  • 当院不育症外来における原発性原因不明習慣流産(primary unexplained recurrent pregnancy loss,puRPL)に対する抗血栓療法の検討

    片倉慧美, 丸山哲夫, 吉政佑之, 富里祥子, 日原華子, 三木史恵, 高尾知佳, 内田明花, 各務真紀, 内田浩, 田中守

    日本生殖医学会雑誌   64 ( 4 )   388 - 388   2019

     More details

    Language:Japanese   Publisher:(一社)日本生殖医学会  

    J-GLOBAL

    researchmap

  • 光応答性ゲノム編集を用いた生殖関連遺伝子発現と生殖機能のin vivo制御システムの構築

    高尾知佳, 丸山哲夫, 吉政佑之, 升田博隆, 内田浩, 内田明花, 片倉慧美, 富里祥子, 田中守

    日本生殖医学会雑誌   64 ( 4 )   311 - 311   2019

     More details

    Language:Japanese   Publisher:(一社)日本生殖医学会  

    J-GLOBAL

    researchmap

  • 上皮間葉転換をターゲットとした子宮内膜症の新規治療戦略

    升田博隆, 高尾知佳, 丸山哲夫, 片渕秀隆, 佐谷秀行, 田中守

    日本分子生物学会年会プログラム・要旨集(Web)   42nd   2019

  • Influence of the orientation of a decellularized uterine scaffold on the tissue topology and architecture of the regenerated uterus in rats

    MIKI Fumie, MARUYAMA Tetsuo, MIYAZAKI Kaoru, TAKAO Tomoka, YOSHIMASA Yushi, KATAKURA Satomi, TOMISATO Shoko, UCHIDA Sayaka, MASUDA Hirotaka, UCHIDA Hiroshi, TANAKA Mamoru, AOKI Daisuke

    日本産科婦人科学会雑誌   71   2019

  • 光応答性CRISPR/CAS9システムによる生殖能のin vivo制御

    高尾知佳, 丸山哲夫, 内田浩, 升田博隆, 内田明花, 三木史恵, 片倉慧美, 吉政佑之, 富里祥子, 田中守, 青木大輔

    日本産科婦人科学会雑誌   71 ( 臨増 )   S - 298   2019

     More details

    Language:Japanese   Publisher:(公社)日本産科婦人科学会  

    J-GLOBAL

    researchmap

  • 光応答性CRISPR/CAS9システムを用いたマウス子宮における胚着床のin vivo制御

    高尾知佳, 丸山哲夫, 吉政佑之, 升田博隆, 内田浩, 内田明花, 片倉慧美, 富里祥子, 佐藤守俊, 田中守

    日本内分泌学会雑誌   95 ( 4 (Web) )   1554 - 1554   2019

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    光応答性CRISPR/Cas9システムが実際にCas9として機能するのか、マウス胚着床を制御することが可能かについて検討した。子宮体癌細胞株Ishikawa(IK)細胞に上皮マーカーであるEpCAMプロモーターEp-Prを挿入したLuciferase誘導細胞株としてIK-Ep-Pr細胞を作製し、このEpCAMプロモーターに対し特異的なsgRNA(sgProm)と対照群のコントロールsgRNA(sgCtrl)を作製した。腫瘍内および腹腔内両者ともにLuciferase活性が抑制されていることが確認され、in vitroおよびin vivoともに光Cas9が機能することが明らかとなった。さらに、光Cas9で制御される胚着床モデルの作製を行った。4.5日目のマウス子宮を調べた結果、妊娠コントロール群で強いleukemia inhibitory factor(LIF)発現が認められたが、LED照射を行ったノックアウト群ではLIFの発現が減少していた。7.5日目のマウス子宮内胎児数では、妊娠コントロール群に比較してノックアウト群ではその数が有意に減少していた。光Cas9を用いてin vivo胚着床モデルの作製が可能となった。

    J-GLOBAL

    researchmap

  • 光応答性CRISPR/CAS9システムによるマウス生殖能のin vivo制御

    高尾知佳, 吉政佑之, 升田博隆, 内田浩, 内田明花, 片倉慧美, 富里祥子, 田中守, 佐藤守俊, 丸山哲夫

    日本分子生物学会年会プログラム・要旨集(Web)   42nd   2019

  • ヒト正常子宮平滑筋細胞に対する子宮筋腫関連遺伝子MED12の変異導入による機能的病因解析

    高尾 知佳, 丸山 哲夫, 内田 浩, 内田 明花, 三木 史恵, 片倉 慧美, 吉政 佑之, 冨里 祥子, 升田 博隆, 田中 守

    日本内分泌学会雑誌   94 ( 4 )   1441 - 1441   2018.12

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • Extravillous trophoblastの新しいマーカーとしてのG蛋白共役型受容体P2RY14とその細胞浸潤における役割

    片倉 慧美, 丸山 哲夫, 高尾 知佳, 瀬田 康弘, 吉政 佑之, 富里 祥子, 三木 史恵, 内田 明花, 升田 博隆, 内田 浩, 田中 守, 青木 大輔

    日本産科婦人科学会雑誌   70 ( 2 )   881 - 881   2018.2

     More details

    Language:Japanese   Publisher:(公社)日本産科婦人科学会  

    researchmap

  • 子宮内膜幹細胞と上皮間葉転換をターゲットとした非内分泌的な子宮内膜症の新規治療

    升田博隆, 古谷正敬, 丸山哲夫, 高尾知佳, 内田浩, 内田明花, 吉政佑之, 片倉慧美, 吉村泰典, 片渕秀隆, 田中守

    日本内分泌学会雑誌   94 ( 4 )   1426 - 1426   2018

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    J-GLOBAL

    researchmap

  • 子宮体癌細胞の幹様細胞とそれを治療標的とする既存薬の探索

    高尾知佳, 升田博隆, 三木史恵, 片倉慧美, 吉政佑之, 冨里祥子, 内田明花, 内田浩, 田中守, 丸山哲夫

    日本分子生物学会年会プログラム・要旨集(Web)   41st   2018

  • CRISPR/CAS9システムによりMED12変異を導入したヒト子宮筋腫モデルの開発の試み

    高尾知佳, 丸山哲夫, 小野政徳, 内田浩, 升田博隆, 内田明花, 三木史恵, 片倉慧美, 吉政佑之, 藤原浩, 田中守, 青木大輔

    日本産科婦人科学会雑誌   70 ( 2 )   927 - 927   2018

     More details

    Language:Japanese   Publisher:(公社)日本産科婦人科学会  

    J-GLOBAL

    researchmap

  • ヒト子宮細胞を用いた子宮腺筋症モデル構築の試み

    吉政佑之, 丸山哲夫, 宮崎薫, 高尾知佳, 片倉慧美, 日原華子, 富里祥子, 内田明花, 内田浩, 升田博隆, 田中守

    日本エンドメトリオーシス学会学術講演会プログラム・抄録集   38th   2017

  • 口腔の痛覚受容解明への新たなアプローチ 口腔粘膜の痛みとTRPV1チャネル

    城戸 瑞穂, 吉住 潤子, 高尾 知佳, 吉本 怜子, 大山 順子, 合島 怜央奈, 高岡 裕, 豊福 明

    Journal of Oral Biosciences Supplement   2016   122 - 122   2016.9

     More details

    Language:Japanese   Publisher:(一社)歯科基礎医学会  

    researchmap

  • 口腔粘膜の痛みとTRPV1チャネル

    城戸瑞穂, 城戸瑞穂, 吉住潤子, 高尾知佳, 吉本怜子, 大山順子, 合島怜央奈, 高岡裕, 豊福明

    Journal of Oral Biosciences Supplement (Web)   2016   2016

  • ヒト病態をin vitro/in vivoで再現した新規子宮内膜症モデルの構築

    梶谷 宇, 高尾 知佳

    日本内分泌学会雑誌   91 ( 1 )   340 - 340   2015.4

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    researchmap

  • ヒト子宮内膜症モデル細胞におけるAd4BP/SF-1の新たな役割

    高尾知佳, 梶谷宇

    日本エンドメトリオーシス学会プログラム・抄録集   36th   2015

  • ヒト子宮内膜症モデル細胞におけるAd4BP/SF-1の新たな役割

    高尾知佳, 岡田瞳, 梶谷宇

    日本内分泌学会雑誌   91 ( 1 )   300 - 300   2015

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    J-GLOBAL

    researchmap

  • ヒト子宮内膜症モデル細胞におけるAd4BP/SF-1の新たな役割

    高尾知佳, 梶谷宇

    日本内分泌学会雑誌   90 ( 2 )   679 - 679   2014

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    J-GLOBAL

    researchmap

  • ダイオキシン受容体は一塩基多型依存的に転写制御され、子宮体癌の増殖・浸潤に関わる

    浅野間 和夫, 高尾 知佳, 恒松 良祐, 諸隈 誠一, 福嶋 恒太郎, 小林 裕明, 齋藤 俊章, 加藤 聖子, 和氣 徳夫

    日本婦人科腫瘍学会雑誌   31 ( 3 )   435 - 435   2013.6

     More details

    Language:Japanese   Publisher:(公社)日本婦人科腫瘍学会  

    researchmap

  • ヒト病態をin vitro/in vivoで再現した新規子宮内膜症モデルの構築

    梶谷宇, 高尾知佳

    日本内分泌学会雑誌   89 ( 2 )   656 - 656   2013

     More details

    Language:Japanese   Publisher:(一社)日本内分泌学会  

    J-GLOBAL

    researchmap

  • TRPV3チャネルは温度を感受し口腔粘膜の創傷治癒を促進する

    城戸瑞穂, 合島怜央奈, 高尾知佳, 王冰, 大崎康吉, 張旌旗

    日本解剖学会総会・全国学術集会講演プログラム・抄録集   118th   2013

  • ISOLATION AND CHARACTERIZATION OF HUMAN TROPHOBLAST PROGENITOR CELLS IN PRIMARY VILLOUS CYTOTROPHOBLASTS AND HTR-8/SVNEO CELL LINE

    Tomoka Takao, Kazuo Asanoma, Norio Wake

    PLACENTA   33 ( 9 )   A27 - A27   2012.9

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:W B SAUNDERS CO LTD  

    Web of Science

    researchmap

  • AHRプロモータ上のSNPとNF1Cの転写制御は癌の進展に関与する

    高尾知佳, 浅野間和夫, 和氣徳夫

    日本分子生物学会年会プログラム・要旨集(Web)   35th   2012

  • The analysis of human trophoblast side-population (SP) cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line

    Tomoka Takao, Kazuo Asanoma, Kiyoko Kato, Kotaro Fukushima, Hiroyuki Seki, Satoru Takeda, Norio Wake

    PLACENTA   32 ( 9 )   A168 - A168   2011.9

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:W B SAUNDERS CO LTD  

    Web of Science

    researchmap

  • Functional analysis of Tssc3 in mouse trophoblast stem cells

    TAKAO Tomoka, ASANOMA Kazuo, TSUNEMATSU Ryosuke, WAKE Norio

    日本分子生物学会年会プログラム・要旨集(Web)   34th   2011

  • ヒトTrophoblast stem like cellsの単離と同定

    高尾 知佳, 岡本 加奈子, 李 丹, 加藤 聖子, 和気 徳夫

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   83回・33回   2P - 0803   2010.12

     More details

    Language:Japanese   Publisher:(公社)日本生化学会  

    researchmap

  • サイトメトリー技術の進歩と細胞診断学への応用 子宮体癌細胞のstem like cellの同定と生物学的特性の解析

    加藤 聖子, 高尾 知佳, 大神 達寛, 山口 真一郎, 米田 智子, 田中 義弘, 和氣 徳夫

    日本臨床細胞学会雑誌   47 ( Suppl.1 )   97 - 97   2008.3

     More details

    Language:Japanese   Publisher:(公社)日本臨床細胞学会  

    CiNii Article

    CiNii Books

    researchmap

▼display all

Presentations

  • ヒト多能性幹細胞を使用した四肢骨格形成過程の人為的再構築

    髙尾知佳, 中村正裕, 山田大祐, 宝田剛志

    Brainstorming 2022 at Junko Fukutake Hall  2022.8.27 

     More details

    Event date: 2022.8.27

    Presentation type:Poster presentation  

    researchmap

  • ヒトiPS細胞由来肢芽間葉系細胞の発生機序の検討

    髙尾知佳, 大曽根達則, 山田大祐, 中田英二, 尾﨑 敏文, 宝田剛志

    第38回日本整形外科学会基礎学術集会  2023.10 

     More details

  • Production of hyaline cartilage sheet using human induced pluripotent stem cell-derived chondrocyte precursor cells

    Tomoka Takao

    日本組織培養学会 第95回大会  2023.8 

     More details

  • ヒトiPS細胞から誘導した肢芽間葉系細胞による軟骨シートの開発

    髙尾知佳, 佐藤正人, 豊田恵利子, 藤澤佑樹, 山田大祐, 中田英二, 尾﨑 敏文, 宝田剛志

    第22回日本再生医療学会総会  2023.3 

     More details

  • ヒト多能性幹細胞由来の肢芽間葉系細胞を用いた軟骨細胞シートの作製と軟骨再生医療への応用の可能性

    髙尾知佳, 佐藤正人, 豊田恵利子, 藤澤佑樹, 山田大祐, 中田英二, 尾﨑敏文, 宝田剛志

    第35回日本軟骨代謝学会  2023.3 

     More details

  • ヒトiPS細胞来肢芽間葉系細胞を用いた硝子軟骨シートの作製

    髙尾知佳, 山田大祐, 佐藤正人, 中田英二, 尾﨑 敏文, 宝田剛志

    第37回日本整形外科学会基礎学術集会  2022.10 

     More details

  • マウス骨髄内LepR陽性細胞中の細胞不均一性の解析

    髙尾知佳, 中村正裕, 山田大祐, 宝田剛志

    第42回日本骨形態計測学会  2022.6 

     More details

  • 一細胞遺伝子発現解析によるPrrx1陽性肢芽間葉細胞の不均一性の解析

    髙尾知佳, 中村正裕, 明璐, 山田大祐, 北條宏徳, 宝田剛志

    第34回日本軟骨代謝学会  2022.2 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • Heterogeneity and its hierarchy of Prrx1-positive cells during limb development

    Tomoka Takao

    ANZBMS 2021  2021.11 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • マウス四肢骨格発生過程の一細胞遺伝子発現解析

    髙尾知佳、 中村正裕, 山田大祐, 宝田剛志

    第39回日本骨代謝学会学術集会  2021.10 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • 光応答性CRISPR/CAS9システムを用いたマウス子宮における胚着床のin vivo制御

    髙尾知佳

    第24回日本生殖内分泌学会学術集会  2020.1 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • 光応答性CRISPR/CAS9システムによる生殖能のin vivo制御

    髙尾知佳、升田博隆、佐藤守俊、丸山哲夫.

    第42回日本分子生物学会年会  2019.12 

     More details

    Presentation type:Poster presentation  

    researchmap

  • 光応答性ゲノム編集を用いた生殖関連遺伝子発現と生殖機能のin vivo制御システムの構築

    髙尾知佳

    第64回日本生殖医学会学術講演会・総会  2019.11 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • 光応答性CRISPR/CAS9システムによる生殖能のin vivo制御

    髙尾知佳

    第71回日本産科婦人科学会学術講演会  2019.4 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • ヒト正常子宮平滑筋細胞に対する子宮筋腫関連遺伝子 MED12の 変異導入による機能的病因解析

    髙尾知佳

    第23回日本生殖内分泌学会学術集会  2018.12 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • 子宮体癌細胞の幹様細胞とそれを治療標的とする既存薬の 探索;Effects of candidate drugs targeting cancer stem-like cells in endometrial carcinoma cell line

    髙尾知佳

    第41回日本分子生物学会年会  2018.11 

     More details

    Presentation type:Poster presentation  

    researchmap

  • CRISPR/CAS9 システムにより MED12 変異を導入したヒト 子宮筋腫モデルの開発の試み

    髙尾知佳

    第70回日本産科婦人科学会学術講演会  2018.5 

     More details

    Presentation type:Poster presentation  

    researchmap

  • ヒト子宮内膜症モデル細胞におけるAd4BP/SF-1の新たな役割

    髙尾知佳

    第88回日本内分泌学会学術集会  2015.4 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • ヒト子宮内膜症モデル細胞におけるAd4BP/SF-1の新たな役割

    髙尾知佳

    第19回日本生殖内分泌学会学術集会  2015.1 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • ヒト子宮内膜症モデル細胞における Ad4BPSF1の新たな役割

    髙尾知佳

    第36回日本エンドメトリオーシス学会学術講演会  2015.1 

     More details

    Presentation type:Oral presentation (general)  

    researchmap

  • ヒト子宮内膜症モデル細胞におけるAd4BP/SF-1の新たな 役割

    髙尾知佳

    日本内分泌学会第32回内分泌代謝学サマーセミナー  2014.7 

     More details

    Presentation type:Poster presentation  

    researchmap

  • Isolation and characterization of human trophoblast progenitor cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line

    Tomoka Takao

    International Federation of Placenta Associations (IFPA) 2012  2012.9 

     More details

    Presentation type:Poster presentation  

    researchmap

  • 1塩基多型(SNPs)依存的なAryl Hydrocarbon Receptor(AHR)の転写制御

    髙尾知佳

    平成24年度環境研究総合推進費「ダイオキシン類暴露による継世代健康影響と遺伝的感受性要因との関連に関する研究」アドバイザリー会合  2012.7 

     More details

  • 1塩基多型(SNPs)依存的なAryl Hydrocarbon Receptor(AHR)の転写制御

    髙尾知佳

    平成24年度厚生労働省全国油症治療研究班会議  2012.6 

     More details

  • Functional analysis of Tssc3 in mouse trophoblast stem cells

    2011.12 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • ヒトTrophoblast stem like cellsの単離と同定/Isolation and Identification of human trophoblast stem-like cells in trophoblast cells

    髙尾知佳

    第33回日本分子生物学会年会 第83回日本生化学会大会 合同大会  2010.12 

     More details

    Presentation type:Poster presentation  

    researchmap

  • Isolation and identification of Side population cells in Human trophoblast cell line

    髙尾知佳

    第32回日本分子生物学会年会 MBSJ2009  2009.12 

     More details

    Presentation type:Poster presentation  

    researchmap

  • マウス栄養膜幹細胞におけるTssc3の機能解析

    髙尾知佳

    第14回生殖医学フォーラム  2009.9.18 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • マウスTS細胞(栄養膜幹細胞)におけるTssc3の機能解析

    髙尾知佳

    第31回日本分子生物学会年会 第81回日本生化学会大会 合同大会BMB2008  2008.12 

     More details

    Presentation type:Poster presentation  

    researchmap

▼display all

Industrial property rights

  • [2] 形状型軟骨組織体の調製方法

    宝田剛志, 木股敬裕, 太田智之, 髙尾知佳, 岩井良輔

     More details

    Applicant:岡山大学、岡山理科大学

    Application no:特願2021-145753  Date applied:2021.9.7

    researchmap

  • LBM、CPC、OPC、それらの調製方法及び品質管理方法、キット、移植材料並びに疾患モデル

    宝田剛志, 山田大祐, 髙尾知佳, 戸口田淳也, 吉富啓之

     More details

    Applicant:宝田剛志(岡山大学)

    Application no:特願PCT/JP2020/035517  Date applied:2020.9.18

    researchmap

Awards

  • 最優秀口演賞

    2024.2   第36回日本軟骨代謝学会   ヒトiPS細胞由来肢芽間葉系細胞を用いた四肢形成機序の検討

    高尾知佳, 大曾根達則, 山田大祐, 宝田剛志

     More details

  • award

    2023.10   Limb development lineage of human induced pluripotent stem cell-derived limb bud mesenchymal cells

     More details

  • English Presentation Award (EPA)

    2023.9   第95回日本組織培養学会   Production of hyaline cartilage sheet using human induced pluripotent stem cell- derived chondrocyte precursor cells

    Tomoka Takao

     More details

  • Brainstorming 2022 研究奨励賞

    2022.8   岡山大学   ヒト多能性幹細胞を使用した四肢骨格形成過程の人為的再構築

    髙尾知佳, 中村正裕, 山田大祐, 宝田剛志

     More details

  • Academic Encouragement Award

    2021.11   Japan Society for Reproductive Medicine   Optogenetic regulation of embryo implantation in mice using photoactivatable CRISPR/Cas9

    Tomoka Takao

     More details

  • Excellence Award for the 3rd SMF Paper Award Project

    2021.11   Optogenetic regulation of embryo implantation in mice using photoactivatable CRISPR-Cas9

     More details

  • ANZBMS 2021 Travel Award

    2021   日本骨代謝学会  

     More details

  • 学術奨励賞

    2020.1   第24回日本生殖内分泌学会学術集会   光応答性CRISPR/CAS9システムを用いたマウス子宮における胚着床のin vivo制御

    髙尾知佳

     More details

  • 高得点日本語演題賞

    2019.4   第71回日本産科婦人科学会学術講演会   光応答性CRISPR/CAS9システムによる生殖能のin vivo制御

    高尾 知佳

     More details

  • Y.W. Loke New Investigator Travel Awards

    2012.9   International Federation of Placenta Associations (IFPA)   Isolation and characterization of human trophoblast progenitor cells in primary villous cytotrophoblasts and HTR-8/SVneo cell line

    Tomoka Takao

     More details

▼display all

Research Projects

  • ヒト軟骨前駆細胞を利用した気道狭窄疾患再生医療等製品の開発に向けた基礎研究

    2024.08 - 2027.03

    国立研究開発法人日本医療研究開発機構(AMED)  令和6年度「再生・細胞医療・遺伝子治療実現加速化プログラム(再生・細胞医療・遺伝子治療研究開発課題(基礎応用研究課題))」(若手) 

      More details

    Authorship:Principal investigator 

    researchmap

  • ヒト関節軟骨オルガノイドを利用した変形性関節症治療薬の開発

    2024.04

    公益財団法人 中冨健康科学振興財団  令和5年度(第36回)研究助成金 

    高尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • ヒトiPS細胞由来軟骨前駆細胞を利用した先天性気管狭窄症に対する新規治療法の開発

    2024 - 2025.03

    公益財団法人 川野小児医学奨学財団  令和6年度 研究助成 

      More details

    Authorship:Principal investigator 

    researchmap

  • ヒトiPS細胞由来肢芽間葉系細胞による変形性関節症の遺伝・環境複合素因に関する研究

    Grant number:23K08677  2023.04 - 2026.03

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    高尾 知佳

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    researchmap

  • 光in vivoイメージングを用いた変形性関節症モデル及び薬剤スクリーニングシステムの開発

    2022.08 - 2027.03

    公益財団法人 武田科学振興財団  ビジョナリーリサーチ助成(スタート)  研究助成

    高尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • iPS細胞由来ヒト軟骨前駆細胞ペースト(Chondro-paste)の開発(継続)

    2022.04 - 2023.03

    橋渡し研究戦略的推進プログラム 岡山大学拠点  橋渡し研究戦略的推進プログラム シーズA 

    高尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • ヒト関節軟骨オルガノイドを利用した革新的創薬スクリーニング技術の開発

    Grant number:21H02643  2021.04 - 2025.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    宝田 剛志, 高尾 知佳, 山田 大祐, 戸口田 淳也

      More details

    Authorship:Coinvestigator(s) 

    Grant amount:\17160000 ( Direct expense: \13200000 、 Indirect expense:\3960000 )

    高齢化が急速に進行する中で、膝関節軟骨の代表的疾患である変形性関節症(Osteoarthritis, OA)に対する薬物治療開発は遅々として進んでいない。ヒト生体環境/病態を模倣したハイスループット化合物スクリーニングシステムの開発は、薬剤開発の初期段階に極めて重要であるが、ヒト関節軟骨組織(硝子軟骨組織)を均一大量に調整することは従来不可能であった。申請者は、ヒト多能性幹細胞より、高い軟骨分化指向性を有し、拡大培養可能で、前向き品質管理が可能なヒト軟骨前駆細胞を大量に調整する技術を開発することに成功し、「ヒト」の硝子軟骨組織(=ヒト関節軟骨オルガノイド)を「均一・大量」に、安定的に調整する準備が整った。本研究では、開発したヒト軟骨前駆細胞を細胞源とし、均一大量に作製したOA病態ヒト関節軟骨オルガノイドによるハイスループット化合物スクリーニング系を開発することで、OA治療候補化合物を同定し、独自に開発する疾患モデル動物での治療効果を検証することを目指す。この点において本年度は、ヒト多能性幹細胞株にpiggybacでのDOX inducible RUNX2発現カセットを導入し (hPSC-iRUNX2株の樹立)、同株より申請者らの開発した方法を使用して、ヒト軟骨前駆細胞(hCPC-iRUNX2)を樹立し、継代培養により増やした。DOXを添加することでRUNX2の発現が認められ系の確立に成功した。

    researchmap

  • 軟骨再生による変形性足関節症に対する新規治療の開発

    Grant number:24K12374  2024.04 - 2027.03

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    雑賀 建多, 中田 英二, 宝田 剛志, 尾崎 敏文, 高尾 知佳

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    researchmap

  • Development of new treatment for cartilage regeneration for hip osteoarthritis

    Grant number:23K08590  2023.04 - 2026.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    山田 和希, 中田 英二, 宝田 剛志, 尾崎 敏文, 高尾 知佳, 山田 大祐

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    researchmap

  • Development of human-derived extracellular matrix product using scaffold-free tissue-engineered cartilage

    Grant number:23K09099  2023.04 - 2026.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    太田 智之, 宝田 剛志, 高尾 知佳

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    researchmap

  • ヒト肢芽間葉系細胞由来のEVを用いた軟骨修復治療の検討

    2022.12 - 2023.03

    岡山大学  令和 4 年度男女共同参画室「女性教員支援助成金【研究費配分型】」 

      More details

    Authorship:Principal investigator 

    researchmap

  • ヒト肢芽間葉系細胞を細胞源とした軟骨関連疾患に対する創薬スクリーニング方法の開発

    2022.11 - 2023.12

    公益財団法人 持田記念医学薬学振興財団  2022年度持田記念研究助成金  研究助成

    髙尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • 増悪因子間の相互作用を標的とした新規肉腫治療薬コンセプトの検証

    Grant number:DNW-22022  2022.10 - 2023.09

    国立研究開発法人日本医療研究開発機構(AMED)  創薬総合支援事業 (創薬ブースター)  創薬ブースター

    山田大祐, 宝田剛志, 髙尾知佳, 尾﨑敏文, 中田英二

      More details

    Grant type:Competitive

    Grant amount:\13959000 ( Direct expense: \12690000 、 Indirect expense:\1269000 )

    researchmap

  • 新規肉腫モデルを用いた肉腫発生メカニズムの解明と治療標的分子同定の試み

    Grant number:22K09378  2022.04 - 2025.03

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    上原 健敬, 中田 英二, 宝田 剛志, 尾崎 敏文, 高尾 知佳, 山田 大祐

      More details

    Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )

    researchmap

  • Development of new molecular targeted therapy for osteosarcoma lung metastasis

    Grant number:22K09401  2022.04 - 2025.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    中田 英二, 宝田 剛志, 尾崎 敏文, 高尾 知佳, 山田 大祐

      More details

    Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )

    researchmap

  • 新しい軟骨移植素材を用いた軟骨再生の開発

    Grant number:22K09356  2022.04 - 2025.03

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    宮澤 慎一, 中田 英二, 尾崎 敏文, 高尾 知佳, 山田 大祐

      More details

    Grant amount:\4290000 ( Direct expense: \3300000 、 Indirect expense:\990000 )

    researchmap

  • 関節軟骨の光in vivoイメージング技術の開発

    Grant number:22K09332  2022.04 - 2025.03

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    鉄永 智紀, 中田 英二, 宝田 剛志, 尾崎 敏文, 高尾 知佳, 山田 大祐

      More details

    Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )

    researchmap

  • ヒト軟骨前駆細胞を使用した創薬Screening技術の開発

    2021.12 - 2023.09

    公益財団法人 アステラス病態代謝研究会  研究助成 

    高尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • 光技術を用いたヒトiPS細胞由来関節組織構築モデルの開発

    2021.12 - 2022.12

    公益財団法人 岡山医学振興会  研究助成 

    高尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • 光操作技術を利用した時間・空間・細胞種特異的な細胞ラベリング技術の開発と、生体内細胞動態研究への応用

    2021.09 - 2022.09

    公益財団法人 両備檉園  研究助成 

    高尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • ヒト関節オルガノイドを用いた関節病態の理解と、治療薬の開発

    2021.09 - 2022.08

    公益財団法人 寺岡記念育英会  研究活動費助成 

    高尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • Analysis of taste function in oral-brain-gut axis using new photogenetical tool

    Grant number:21K19601  2021.07 - 2024.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Research (Exploratory)  Grant-in-Aid for Challenging Research (Exploratory)

    吉田 竜介, 古株 彰一郎, 高尾 知佳

      More details

    Grant amount:\6370000 ( Direct expense: \4900000 、 Indirect expense:\1470000 )

    本年度は、野生型マウスおよび全身で甘味受容体コンポーネントを欠損するT1R3-KOマウスを用い、グルコースを口腔から摂取した場合と胃内投与した場合の血糖値および血中インスリン濃度の経時的変化(0~120分)について調べた。マウスをリック装置から溶液を摂取する様トレーニングし、グルコース摂取量が1mg/g体重となるよう2Mグルコースを摂取させた場合(口腔摂取)と同量を直接胃内投与した場合とを比較すると、血糖値のピークはいずれのマウスにおいても口腔摂取した方が早く(およそ摂取後10分)、胃内投与した場合には遅くなっていた(およそ摂取後30分)。血漿インスリン濃度についても同様の差が見られた。この結果から、口腔からグルコースを摂取した場合には頭相インスリン分泌が見られ、これがグルコース摂取後の血糖値変化を影響を与えるものと考えられる。また、甘味受容体T1R2/T1R3を介さない口腔からの何らかの感覚情報が重要であると考えられる。
    また、光KOマウス作成について、開発済みのTet offシステムにより光活性化-Cre(PA-Cre)発現を制御するTRE-PA-Creマウスと、全身的にテトラサイクリン調節性トランス活性化因子(tTA)を発現するROSA-tTAマウスを開発し掛け合わせ、全身でPA-Creを発現するマウス(PA-Cre)を作成する予定であったが、ROSA-tTAマウスを取得することが出来なかったため、全身性PA-Creマウスはまだ作成できていない。

    researchmap

  • ヒト肉腫自然発症モデルを利用した血中悪性化指標マーカーの探索

    Grant number:21K07192  2021.04 - 2024.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    山田 大祐, 中田 英二, 宝田 剛志, 高尾 知佳

      More details

    Authorship:Coinvestigator(s) 

    Grant amount:\4290000 ( Direct expense: \3300000 、 Indirect expense:\990000 )

    申請者らは、ヒト骨肉種では転写制御因子PRRX1が高発現していることを見出しているだけでなく、PRRX1の発現量が高い患者は予後不良を示すことも明らかにしている。さらに、マウス骨肉腫モデルでもPRRX1が発現しているだけでなく、ヒト骨肉腫細胞株143Bにおいては、PRRX1のノックダウンによって増殖性や浸潤性が低下するだけでなく、ドキソルビシンとシスプラチンへの抵抗性が解除されることも見出している。これらの研究実績は、Transl Oncol 誌(2021 Vol. 14 Issue 1 Pages 100960)にて発表を行い、骨肉腫におけるPRRX1の増悪因子としての機能を明らかにした。その後、悪性神経鞘腫においてもPRRX1が増悪因子として機能することも見出しており(未発表データ)、肉腫におけるPRRX1の重要性が明らかになってきている。また、Nature Biomedical Engineering誌(2021 Vol. 5 Issue 8 Pages 926-940)にて、ヒト多能性幹細胞から発生過程を模倣した分化誘導方法を用いて、肢芽間葉系細胞を作成する技術に関しての発表を行い、本研究課題を遂行するための研究ツールの開発にも成功している。研究成果は、AMED及び申請者の所属機関である岡山大学にてプレスリリースを行い、一般向けの内容紹介を掲載して公開されている。さらに、ヒト多能性幹細胞から作成した肺オルガノイドを用いて、前がん病変を再現することにも成功している(Int J Cancer 2021 Vol. 149 Issue 8 Pages 1593-1604)。以上の結果から、ヒト多能性幹細胞を用いた腫瘍モデルを構築するための実験技術に関しては、十分整っていると考えられる。

    researchmap

  • iPS細胞由来ヒト軟骨前駆細胞ペースト(Chondro-paste)の開発

    2021.04 - 2022.03

    橋渡し研究戦略的推進プログラム 岡山大学拠点  橋渡し研究戦略的推進プログラム シーズA 

    高尾知佳

      More details

    Authorship:Principal investigator 

    researchmap

  • 光活性型Creシステムを利用した生体内遺伝子操作法の開発

    Grant number:20K21373  2020.07 - 2023.03

    日本学術振興会  科学研究費助成事業 挑戦的研究(萌芽)  挑戦的研究(萌芽)

    宝田 剛志, 高尾 知佳, 山田 大祐, 佐藤 守俊

      More details

    Grant amount:\6370000 ( Direct expense: \4900000 、 Indirect expense:\1470000 )

    生体内遺伝子操作の精度(時期特異性や、細胞種特異性)は、Cre recombinase (Cre)loxP 部位特異的 DNA組換え酵素反応の応用により格段に上昇した。青光照射でDNA組み換え反応をコントロールできる光活性型Cre(Photoactivatable(PA)-Cre)に着目し、このPA-Cre技術と、テトラサイクリン誘導発現系システム(TetON/OFF)のActb locusへのノックイン技術を組み合わせることで、in vivoでのlight/Dox-dependentなDNA組み換え反応を可能とする遺伝子改変マウス(TRE-PA-Creマウス)の開発に成功した。同マウスを使用することで、個体レベルでの光活性型Creシステムの有用性を実証し、免疫/幹細胞の細胞動態研究(例:どのタイミングで傷害部位へ遊走し、遊走後どれくらい滞在するのか?遊走後の細胞は分化/機能変化の点でどのような運命を辿るのか?)や、がん研究(例:遺伝子変異細胞の動態を極めて早期に生体内で観察)への応用を目指す。本年度は、昨年作成した各種tTAマウス(ROSA-tTA:全身性にtTAを発現するマウス、Foxp3-tTAマウス:制御性T細胞にてtTAを発現するマウス、LepR-tTAマウス:LepR陽性間葉系間質細胞にてtTAを発現するマウス)とTRE-PA-Creマウス、LSL-tdTomatoマウスを交配し、各種tTA;PA-Crel;tdTomatoマウスを作製した。qPCRにより、それぞれの細胞種にてtTAを発現することを確認した。

    researchmap

  • Optogenetic regulation of function, regeneration and diseases of the female reproductive organ using stem cell and genome editing technologies

    Grant number:20H03826  2020.04 - 2023.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    丸山 哲夫, 佐藤 守俊, 高尾 知佳, 升田 博隆, 内田 浩, 宮崎 薫

      More details

    Grant amount:\17680000 ( Direct expense: \13600000 、 Indirect expense:\4080000 )

    令和3年度は,これまでわれわれが行ってきた部分的な子宮の再生・再建の技術と基盤知見をもとに,ラットを用いて子宮機能の中心的な役割を担う子宮内膜の全層再建・再生技術の開発を行った.その結果,脱細胞化子宮内膜骨格 (Decellularized Endometrial Scaffolds, DES)を用いることで,より効率的に子宮内膜の全層再生が促されることが判明した.さらに光遺伝操作と再細胞化(再生)に適した細胞の候補として,様々な子宮内膜由来細胞(正常・不死化・癌細胞)とその幹細胞について検討を行ったところ,ある内膜癌幹細胞株が安定期に幹細胞特性を有することが明らかになり,その幹細胞特性や再生医療への応用について検討した.また子宮全体の再生および子宮疾患の代表である子宮筋腫の病因メカニズムの解明の観点から,ヒト子宮平滑筋細胞に光応答性ゲノム編集ではなく通常のゲノム編集による遺伝操作を加えて増生能力の増強や造腫瘍能の獲得の有無などを検討したところ,一部に変化は見られたが予想していた特性は付与されず,その原因として用いた細胞が平滑筋幹細胞では無かったことが考えられた.また,光応答生ゲノム編集技術の改善・改良と新しい研究ツールや治療法としての妥当性を検証するべく, 着床に関連する挙動を示すものの機能不明の新しい分子を光応答性ゲノム編集の標的分子として基礎的解析も行った.異所性に子宮内膜様病変を作成して子宮内モデルを構築する際に,内膜症候補細胞を搭載したDESや磁性体などを用いて細胞を集積するなどの技術が必要となるが,その技術開発も行った.

    researchmap

  • Optogenetic regulation of embryo implantation in mice using photoactivatable CRISPR-Cas9

    Grant number:19K18705  2019.04 - 2022.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Early-Career Scientists  Grant-in-Aid for Early-Career Scientists

    Takao Tomoka

      More details

    Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )

    Implantation occurs through the interaction between the fertilized egg and the endometrium and is mediated by the spatiotemporal expression of implantation-related molecules including leukemia inhibitory factor (LIF). In this study, we demonstrated that knockdown of LIF by a photoactivatable CRISPR-Cas9-based genome editing system using blue LED illumination can regulate implantation in a spatiotemporal manner in mice. We believe that this system can be used in the future to elucidate the spatiotemporal molecular mechanisms involved in embryo implantation and to apply it to therapeutic strategies by controlling reproductive functions in vivo.

    researchmap

  • Regeneration and functional control of the uterus using decellularization technologies in non-human primates

    Grant number:17K19731  2017.06 - 2019.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Research (Exploratory)  Grant-in-Aid for Challenging Research (Exploratory)

    MARUYAMA Tetsuo, TAKAO Tomoka, MIYAZAKI Kaoru, MIKI Fumie, YOSHIMASA Yushi

      More details

    Grant amount:\6500000 ( Direct expense: \5000000 、 Indirect expense:\1500000 )

    For clinical application of uterine bioengineering to patients with partial uterine defects, we selected the Research Center for Animal Life Science, Shiga University of Medical Research, as the place for primate experiments and prepared staff members and experimental setup. To obtain more solid data towards clinical application, we simultaneously performed rat experiments and found that placement of a decellularized uterine scaffold (DUS) led to the regeneration of endometrium with delineated glandular and luminal structures in rat endometrium defect models. The regeneration efficiency, however, was not as high as expected, so we decided to employ DUS loaded with uterine cells to enhance endometrial regeneration. As one of the most likely candidates as the loading cells, we generated progesterone-responsive endometrial stromal from human induced pluripotent stem cells and showed that WNT/CTNNB1 pathway plays a critical role in the differentiation and generation processes.

    researchmap

  • Development and Molecular regulatory mechanism of mesenchymal epithelial transition (MET) model

    Grant number:16K20189  2016.04 - 2019.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    TAKAO Tomoka

      More details

    Grant amount:\4030000 ( Direct expense: \3100000 、 Indirect expense:\930000 )

    Recently, mesenchymal-epithelial transition (MET) has been involved in many important life phenomena such as tissue and organ formation but not known in this detailed mechanism. Our previous results were shown that mesenchymal stem cells express epithelial-like markers in conditioned culture or in mouse transplantation models. In this study, we aimed to construct a model that reproduces the MET in vitro / in vivo and can be observed in real time. Epithelial-like cells could be reproduced in vivo, but did not reach modeling. However, we found that Raf-MEK or Wnt / β-catenin signaling may be involved in MET by drug researches. It is suggested that these results a foothold of the MET signal.

    researchmap

  • Regulation of uterine endometrial function using photogenetics and tissue engineering: its possible therapeutic potential

    Grant number:16H05474  2016.04 - 2019.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    MARUYAMA Tetsuo, TAKAO Tomoka, MIYAZAKI Kaoru, MIKI Fumie, YOSHIMASA Yushi

      More details

    Grant amount:\17290000 ( Direct expense: \13300000 、 Indirect expense:\3990000 )

    We developed uterine endometrial regeneration technology using decellularized endometrial scaffolds (DES) and photoactivatable CRISPR/CAS9 (paCAS9)-mediated gene editing system to regulate reproductive function in rodents. We showed that placement of DES resulted in the regeneration of endometrium with delineated gland and luminal structures in rat endometrium injury and defect models. Notably, the orientation of the uterine scaffold was important for determination of the tissue topology and architecture of the regenerated uterus. We also found that, in addition to the in vitro gene regulation by paCAS9-mediated gene editing, paCAS was able to regulate uterine gene expression and reproductive functions including uterine embryo receptivity in vivo in response to LED light irradiation. The results of this study provide basic knowledge and technologies to develop a novel therapeutic concept and strategy for restoration and repair of endometrial dysfunction, injury, and defect in humans.

    researchmap

  • Development of uterine leiomyoma model using CRISPR/CAS9 genome editing system

    Grant number:15K15610  2015.04 - 2017.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Exploratory Research  Grant-in-Aid for Challenging Exploratory Research

    MARUYAMA Tetsuo, TAKAO Tomoka

      More details

    Grant amount:\3640000 ( Direct expense: \2800000 、 Indirect expense:\840000 )

    Uterine myometrial cells contained a small but significant amount of stem-like cells immediately after isolation from human myometrial tissues. The number of the stem-like cells, however, decreased considerably when they are cultured in vitro. Instead of myometrial stem-like cells, we introduced MED12 mutations, which are observed in approximately 70 % of uterine leiomyomas, into human myometrium cells using CRISPR/CAS9 system, and analyzed hormone-dependent cell proliferation and collagen expression. Preliminary data showed that MED12 mutation did not affect cell growth but tended to induce collagen expression. In vivo leiomyoma model system is under development.

    researchmap

  • The mechanism of signal for regulating differentiation in human trophoblast stem cells

    Grant number:25462562  2013.04 - 2016.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    TAKAO TOMOKA, WAKE NORIO

      More details

    Grant amount:\4940000 ( Direct expense: \3800000 、 Indirect expense:\1140000 )

    We analyzed the new gene for regulating the differentiation of human trophoblast lineage using HTR-8/SVneo cells. We isolated the 3 trophoblast lineages including each functions; human trophoblast stem/precursor(hTS) cells, syncytiotrophoblast(ST) and extravillous trophoblast(EVT)from HTR-8/SVneo. DNA microarray analysis showed that IFIT2(interferon induced protein with tetratricopeptide repeats 2) was up-regulated in ST cells or TRIB3(tribbles pseudokinase 3)was up-regulated in EVT cells. We transfected its into hTS cells. Upregulation of each gene expression was increased trophoblast differentiated cell markers such as HLAG or HCGB.

    researchmap

  • 子宮内膜細胞の老化逸脱へのゲノム多様性の関与

    Grant number:23249075  2011.11 - 2016.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (A)  Grant-in-Aid for Scientific Research (A)

    和氣 徳夫, 浅野間 和夫, 劉 格, 恒松 良祐, 高尾 知佳, 井上 貴史

      More details

    Grant amount:\30160000 ( Direct expense: \23200000 、 Indirect expense:\6960000 )

    1)子宮内膜細胞の老化逸脱へのゲノム多様性の関与
    MDM2 SNP309 G/G+G/TとTP53コドン72Arg/Argの組み合わせは子宮体癌発症odds比2.53(1.03-6.21)と両遺伝子間に統計学的有意な相互作用を示し、子宮体癌発症リスクを増大する。
    2)AhR-130 C/T SNPによる転写制御
    AhR-130 T/T遺伝子型はC/C遺伝子型に比しmRNAレベルで1.7倍、蛋白レベルで2倍のAhR発現亢進を示した。NF1C転写抑制因子結合サイトがC/C型では維持されT/T型で消失するためである。AhR T/T型の頻度は全体の10%程度であるが進行子宮体癌で有意に高頻度に検出される。AhRが癌細胞にEpithelial Mesenchymal Transition(EMT)を誘発し癌の進展に関与するためである。
    マイクロアレイ法にてAhR下流でTCDD応答性発現変化する遺伝子を同定した。そのうちIL24遺伝子はT/T遺伝子型でC/C遺伝子型に比しTCDD非存在下の発現が有意に亢進しており、TCDD非存在性、AhR依存性AhR転写制御の存在が強く示唆された。TCDD存在下でのIL24発現もT/T型で有意に高値であった。ダイオキシン類高濃度被曝例として、油症患者の血中IL24濃度を測定した。T/T遺伝子型油症患者の血中IL24濃度はC/C遺伝子型と比較し有意に高値であった。これらの結果から、AhR-130bp C/T SNP及びIL24血中濃度はダイオキシン類による病態発症を予知出来るバイオマーカーとして使用可能であることが示唆された。

    researchmap

▼display all

 

Class subject in charge

  • Pracice in Molecular Biology (2024academic year) special  - その他

  • Medical Biology (2024academic year) special  - その他

  • Mystery of Life 2 (2024academic year) Third semester  - 火1~2

  • Practicals: Regenerative Science (2024academic year) special  - その他

  • Research Projects: Regenerative Science (2024academic year) special  - その他

  • Research Projects and Practicals: Regenerative Science I (2024academic year) special  - その他

  • Lecture and Research Projects: Regenerative Science I (2024academic year) special  - その他

  • Research Projects and Practicals: Regenerative Science II (2024academic year) special  - その他

  • Lecture and Research Projects: Regenerative Science II (2024academic year) special  - その他

  • Pracice in Molecular Biology (2023academic year) special  - その他

  • Practicals: Regenerative Science (2023academic year) special  - その他

  • Research Projects: Regenerative Science (2023academic year) special  - その他

  • Research Projects and Practicals: Regenerative Science I (2023academic year) special  - その他

  • Lecture and Research Projects: Regenerative Science I (2023academic year) special  - その他

  • Research Projects and Practicals: Regenerative Science II (2023academic year) special  - その他

  • Lecture and Research Projects: Regenerative Science II (2023academic year) special  - その他

  • Research Projects and Practicals: Regenerative Science I (2022academic year) special  - その他

  • Lecture and Research Projects: Regenerative Science I (2022academic year) special  - その他

  • Research Projects and Practicals: Regenerative Science II (2022academic year) special  - その他

  • Lecture and Research Projects: Regenerative Science II (2022academic year) special  - その他

▼display all

 

Social Activities

  • 時空間特異的遺伝子組み換えを可能にする 新規Creドライバーマウス

    Role(s):Contribution

    理研BRC  今月のマウス  2022.3

     More details

  • Technical note

    Role(s):Contribution

    Journal of Japanese Biochemical Society  2021

     More details

    Type:Other

    researchmap

  • Bimedia

    Role(s):Contribution

    2021

     More details

    Type:Other

    researchmap

  • 光応答性CRISPR/Cas9システムを用いたマウス子宮における胚着床のin vivo制御

    Role(s):Contribution

    日本生殖内分泌学会  日本生殖内分泌学会雑誌  2020.8.31

     More details

    Type:Other

    researchmap

  • 特別講義「子宮と子宮内膜症~新たな子宮内膜症発生機序仮説の提唱~」

    Role(s):Lecturer

    山梨大学生命環境学部  発生工学技術開発・実践特別教育プログラム  2017.6.22

     More details

    Type:Visiting lecture

    researchmap

Media Coverage

  • 高尾知佳講師(医)がAMED「令和6年度再生・細胞医療・遺伝子治療実現加速化プログラム(再生・細胞医療・遺伝子治療研究開発課題(基礎応用研究課題))」に採択

    岡山大学  https://www.okayama-u.ac.jp/tp/news/news_id13256.html  2024.7

     More details

  • ヒトiPS細胞由来肢芽間葉系細胞を用いた新規軟骨細胞シートの作製に成功 Internet

    岡山大学  https://www.okayama-u.ac.jp/tp/release/release_id1064.html  2023.3

     More details

    Author:Myself 

    researchmap

  • ヒト多能性幹細胞から手足の元である肢芽間葉系細胞の誘導・拡大培養に成功―軟骨再生医療やiPS細胞を用いた創薬研究への応用に期待― Internet

    岡山大学  https://www.okayama-u.ac.jp/tp/release/release_id866.html  2021.8

     More details

    Author:Other 

    researchmap

  • 光照射とゲノム編集で妊娠をピンポイントに調節 -不妊治療・避妊・胎内治療への応用に向けて- Internet

    慶應義塾大学  https://www.keio.ac.jp/ja/press-releases/2020/11/4/28-75927/  2020.11

     More details

  • 光によるDNA組換えを可能にするマウス作製に成功 ~テトラサイクリン誘導光応答性Cre-loxPマウス~ Internet

    岡山大学  https://www.okayama-u.ac.jp/tp/release/release_id716.html  2020.3

     More details

    Author:Myself 

    researchmap

Academic Activities

  • ACTA MEDICA OKAYAMA

    Role(s):Peer review

    https://ousar.lib.okayama-u.ac.jp/ja/journal/amo 

     More details

    Type:Peer review 

    researchmap